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Understanding the differential bonding mechanics underlying bleeding disorders 
is of crucial importance to human health. In this research insight is provided into how 
four of these bleeding disorders (each with somewhat similar clinical characteristics), 
work at the molecular bond level.  The bleeding diseases studied here can result from 
defects in the platelet glycoprotein (GP) Ibα, the von Willebrand factor (vWF) molecule, 
or the ADAMTS-13 enzyme.  Types 2B and 2M von Willebrand Disease (VWD) result 
in excess bleeding, yet type 2B has increased binding affinity between platelet GPIbα 
and vWF, while type 2M has decreased binding affinity between these two molecules.  
Platelet type VWD (pt-VWD) causes mutations in the GPIbα molecule and has similar 
characteristics to type 2B VWD.  Further, in thrombotic thrombocytopenic purpura, 
bleeding results when there is a lack of active ADAMTS-13 enzyme.  Each disease 
results in patient bleeding, but due to different mechanisms.  This dissertation will 
explore the bonding mechanics between GPIbα and vWF and how they are altered in 
each disease state.  To observe the GPIbα-vWF bonding mechanics, rolling velocities, 
transient tethering lifetimes, and tether frequency were determined using a parallel plate 
flow chamber.  Data from these experiments suggest that wt-wt interactions are force 
dependent and have biphasic catch-slip bonding behavior.  The data show that the shear 
stress at which the maximum mean stop time occurs differs between gain-of-function and 
loss-of-function mutations.  Using similar methods, we study the changes resulting from 
pt-VWD mutations in GPIbα, and find that the catch bond seen for wt-wt interactions is 
lost for these mutations.  Further, the data suggest that interactions with gain-of-function 
xvii 
 
GPIbα mutations may be transport rather than force dependent.  Finally, how the GPIbα-
vWF tether bond changes for thrombotic thrombocytopenic purpura was also investigated 
to show that the bond lifetime in the absence of the enzyme is increased presenting a 
possible rationale for why bleeding occurs in this disease.   Overall, the data show how 
the bonding mechanics of the GPIbα-vWF tether bond differ in four bleeding diseases.  
Further, these observations offer potential explanations for how these changes in the 









1.1 Thesis Rationale  
Activated platelets mediate the homeostatic response to vascular injuries.  In arteries, 
this response is initiated specifically by platelet receptor glycoprotein (GP) Ibα tethering 
to von Willebrand factor (vWF) on exposed subendothelium.  Platelet GPIbα interacts 
with vWF to initiate rolling interactions that are the first step in the formation of a 
hemostatic plug at a site of vascular injury.  Following this initial step, platelets activate, 
firmly adhere via the GPIIb/IIIa integrin, and aggregate to form the plug and stop 
bleeding [2].  Mutations in either vWF or GPIbα can disrupt this step in hemostasis 
resulting in the bleeding disorders von Willebrand disease (VWD) or platelet type von 
Willebrand disease (pt-VWD), respectively [3].  Disruption of the normal interactions 
between these molecules can also lead to thrombosis as seen in thrombotic 
thrombocytopenic purpura [4].    
Evidence suggests that mutations in either vWF or GPIbα may lead to abnormal 
interactions between platelet GPIbα and soluble vWF.  In Type 2B VWD it is believed 
that increased aggregation of platelets with soluble vWF leads to bleeding due to 
clearance of these aggregates, which results in a lack of unbound GPIbα receptors to 
interact at sites of vascular injury  [5]. 
VWD type 2M loss-of-function (LOF) mutations in vWF or Bernard Soulier 
Syndrome causing mutations in platelet GPIbα show decreased binding affinity resulting 
in increased rolling velocities and off-rates.  These types of mutations are characterized 
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by defective ristocetin binding and normal botrocetin binding.  Type 2M VWD mutant 
G561S shows decreased ristocetin binding and normal multimer number, formation and 
pattern [6].   It is thought that these mutations result in a defect that prevents the vWF 
molecule from undergoing a conformational change that prevents normal binding to 
GPIbα [7]. 
Mutations in the GPIbα molecule have been observed that lead to patient bleeding.   
The binding of these mutations has been shown to be similar to that seen in type 2B 
VWD and is characterized by increased association between GPIbα and vWF [8].   
The overall goal of this research was to investigate both the interactions for wt-wt 
platelet-vWF interactions, as well as for wt-mutant or mutant-wt platelet-vWF 
interactions.  Parallel plate flow chamber experiments were used to mimic physiological 
flow conditions and were conducted at 37oC and interactions were recorded at 250 fps.  
One gain-of-function (GOF) mutation was selected for mutations in platelet GPIbα 
(K237V).  One GOF and one LOF mutation were chosen to represent changes in the 
vWF-A1 domain (R687E and G561S, respectively).   Rolling velocities, mean stop times, 
mean go times, and transient tethering lifetimes were determined to give insight into 
GPIbα-vWF interactions.   
 
1.2 Specific Aims 
1.2.1 Specific Aim I: To Investigate the Rolling Interactions of the Wild-Type GPIbα-




Here it is hypothesized that platelet GPIbα and vWF-A1 interact via a catch bond 
mechanism under normal physiological conditions.  To determine if a catch bond was 
present platelet-vWF interactions were studied to observe trends in several parameters.  
First, rolling velocities were measured for platelets or CHO cells expressing GPIbα 
rolling on vWF molecules.  The trend observed for these interactions indicates the type of 
bond that may be present between these two molecules.  If the velocity decreases with 
increasing shear stress, the data suggest that most likely the bond lifetime is increased as 
the shear stress is increased.  However, if the velocity increases with increasing shear 
stress, the data suggests that the bond lifetime is decreasing with increasing shear stress.  
Increasing bond lifetime with increasing shear stress is suggestive of a region of catch 
bond behavior, while decreasing bond lifetime with increasing shear stress is suggestive 
of a region of slip bond behavior.  To further study rolling interaction and bond lifetimes, 
the mean stop time of the interactions was determined.  Mean stop time, which suggests 
information about the bond lifetime, can be used as an indicator for the off-rate of the 
bond, which is inversely proportional to the bond lifetime.  If the mean stop time 
increases with increasing shear stress, it is likely that the bond lifetime is increased.  This 
result in turn implies that the off-rate for the bond is decreasing with increasing shear 
stress, suggesting that a catch bond is present.  Inversely, if the mean stop time is 
decreasing with increasing shear stress, then the bond lifetime is decreasing and the off-
rate is increasing with increasing shear stress, suggesting the presence of a slip bond.   
Because the bond lifetime may be controlled by either transport or force 
dependent mechanisms, next the rolling velocities and mean stop times were determined 
while changing the viscosity at a given shear rate.  If the experiments are done in medium 
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of increased viscosity, and data align when plotted against shear stress, then the data 
suggests that the interactions are force dependent.  While, if the data align when plotted 
against shear rate, then the data suggest that the interactions are force independent and 
transport dependent.  Because on-rate changes result from transport mechanisms and off-
rate changes result from force mechanisms, it is likely that if the interactions are force 
dependent, then the off-rate would be a controlling parameter and, vice versa, that if the 
interactions are transport dependent, then the on-rate would be a controlling parameter 
for platelet-vWF rolling interactions.   
 
1.2.2 Specific Aim II: To Investigate the Effects of Mutations in the vWF-A1 Binding 
Site on the Biomechanics and Kinetics of Bond Formation and Dissociation.   
 
Here it is hypothesized that mutations in the vWF-A1 domain result in different 
binding properties between platelet GPIbα and vWF molecules.  It is also hypothesized 
that GOF mutations in the vWF-A1 domain result in the loss of a catch bond at lower 
shear stresses under physiological conditions.  Loss of the catch bond could explain how 
increased aggregation of platelets with soluble vWF in type 2B VWD leads to bleeding 
due to clearance of these aggregates or due to a lack of unbound GPIbα receptors to 
interact at sites of vascular injury.  Further, it is hypothesized that LOF mutations in the 
vWF-A1 domain interact with platelets via a catch bond mechanism under physiological 
conditions, but that the catch-slip transition is shifted to higher shear stress.  This shift 
could result in a decreased likelihood that platelet binding will occur under shear stress 
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conditions where the molecule is stabilized because at these higher shear stresses, the 
flow is too great to allow for enough cells to be near the surface long enough to bind.    
To study changes due to VWD states, the GOF mutation R687E and LOF 
mutation G561S were studied in the isolated  vWF-A1 domain and compared to results 
seen for wt vWF molecules.  Interactions between platelets and mutant vWF-A1 domains 
were studied by measuring rolling velocities, mean stop times, and transient tethering 
lifetimes, and were analyzed using the same methods that were used for wt-wt 
interactions.   
1.2.3 Specific Aim III: To Investigate The Effects Of Mutations In the Platelet GPIbα 
Binding Site On the Biomechanics and Kinetics of Bond Formation and 
Dissociation. 
 
Here it is hypothesized that mutations in the GPIbα molecule result in different 
binding between platelet GPIbα and vWF-A1 and that GOF mutations in the GPIbα 
molecule result in the loss of a catch bond at lower shear stresses under physiological 
conditions.  Platelet type VWD is characterized similarly to type 2B VWD, where 
mutations result in bleeding due to increased interactions between GPIbα and vWF.  It is 
believed that the mutations in the GPIbα molecule result in bulk aggregation and 
clearance of platelets.  As with the type 2B VWD mutations, a loss of the catch bond 
could explain increased aggregation between these molecules.   
To study changes due to pt-VWD states, the GPIbα GOF mutation K237V was 
expressed on CHO cells and compared to results seen for wt GPIbα molecules expressed 
on CHO cells and platelets.  Interactions between CHO cells expressing GPIbα (wt or 
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mutant) and the wt vWF-A1 domain were studied by measuring rolling velocities, mean 
stop times, and transient tethering lifetimes, and were analyzed using the same methods 











2.1 Thrombosis and Hemostasis and Normal Physiological GPIbα-vWF Interactions 
at the Vessel Wall 
As described in Chapter 1, activated platelets mediate the homeostatic response to 
vascular injuries.  Normally, interactions between platelet GPIbα and vWF are the first 
interactions in response to a vascular injury.  When vascular injury occurs, vWF located 
in the subendothelial matrix becomes exposed.  The GPIbα receptor located on platelets 
then can interact with the exposed vWF molecule.  In order for rapidly flowing platelets 
to interact with the vWF at the stationary wall, they must first be slowed down.   
 
Figure 2.1:  Platelet response at sites of vascular injury.  When a vascular injury occurs, the 
subendothelial matrix beneath endothelial cells becomes exposed.  Within this matrix are bound 
vWF and collagens.  Platelets in the bulk flow tether to the matrix bound vWF via their GPIbα 
receptors.  These tethers are either converted to rolling on the vWF at the site of injury or the 
platelet flows freely downstream to either return to the bulk flow or tether to another bound vWF 
molecule.  Platelet rolling is converted into firm adhesions upon platelet activation, when the αIIbβ3 
integrin is exposed and binds firmly to the matrix molecules.  Additional platelets and soluble vWF 
molecules are then recruited to the site of injury where vWF acts to bridge platelets and collagen and 














Tethering is the process by which platelet velocity is reduced and is mediated by rapid 
kinetics of binding between the two molecules.  In order for platelets to roll on the vessel 
wall after being slowed, the binding between GPIbα and vWF must be mediated by fast 
on- and off-rates.  These rapid  kinetics for interactions between platelet GPIbα and vWF 
allow platelets to slow down and stay at the vessel wall for the time needed for tethering 
events to be converted into firm adhesions.  Figure 2.1 shows this process.   
In tethering events, GPIbα-vWF interactions allow platelets to transiently bind to the 
vessel wall during injury.  The platelets can then either break loose or the tethering can be 
converted into rolling.  Transient tethering results in a reduction in platelet velocity 
compared to free-flowing platelet velocity.   The reduced velocity of platelets in turn 
allows them to continuously interact with the vessel wall.   It has been suggested that the 
activated platelet undergoes a conformational change revealing the αIIbβ3 integrin. The 
activated αIIbβ3 integrin then interacts with vWF, fibrinogen, and other subendothelial 
matrix proteins such as vitronectin and fibronectin at the vessel wall resulting in stable 
adhesion of platelets [9].  Following firm adhesion of platelets, they are activated through 
a series of signaling events, which leads to platelet spreading across the exposed surface, 
granule release, platelet aggregation, and recruitment of additional platelets and soluble 
vWF from the plasma to form a hemostatic plug [10].   
 
2.2 von Willebrand Disease 
In von Willebrand diseases, which result in patient bleeding, mutations in the vWF 
molecule change the vWF molecule’s ability to bind platelet GPIbα properly.  Several 
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types of VWD have been observed and are separated into three major types: 1, 2, and 3.  
In type 1 VWD, patients have low levels of vWF antigen, but the vWF present binds 
normally.  In type 2 VWD patients have defective vWF binding, where there is either 
enhanced or reduced binding between vWF and its binding partner.  Type 2 VWD is 
further separated into type 2A (decreased number of large vWF multimers), type 2B 
(increased binding to platelet GPIbα), type 2M (decreased binding to platelet GPIbα), 
and type 2N (decreased ability to carry Factor VIII).  In type 3 VWD, patients lack vWF 
protein [11].  For this thesis research, we are interested in how vWF and GPIbα interact 
together, so we have chosen to study mutations causing type 2B and type 2M VWDs.   
 
2.2.1 Type 2B VWD 
Type 2B VWD results from a qualitative defect in the vWF-A1 domain.  These mutations 
result in an increase in the binding between vWF and platelet GPIbα in the presence of 
ristocetin and are defined as gain-of-function mutations [12, 13].  It is believed that this 
increased binding is not due to normal triggers such as vascular injury and increased 
shear stress.  A loss of hemostatically active high molecular weight multimers has been 
observed in type 2B VWD [11].  Further, this increased binding between platelets and 
vWF results in the clearance of platelets and, hence, mild thrombocytopenia.  Figure 2.2 
shows the platelet response at sites of vascular injury when type 2B VWD mutations are 
present.  Here platelets and mutant vWF form aggregates in the bulk.  This model is in 
agreement with the observation that circulating platelets are coated with vWF molecules 
that have the type 2B mutation [11].  With platelets sequestered in these aggregates, there 




Figure 2.2:  Platelet response at sites of vascular injury while type 2B VWD mutations are present in 
the vWF molecule.  As with the normal case in Figure 2.1, when a vascular injury occurs, the 
subendothelial matrix beneath endothelial cells becomes exposed.  Platelets in the bulk flow interact 
with soluble vWF rather than tethering to the matrix bound vWF via their GPIbα receptors.  
Because platelets are sequestered in these platelet/vWF aggregates, they are unable to tether at sites 
of injury.  The result is that there are fewer platelets available to initiate rolling interactions at the 
injury site, resulting is delayed hemostatic plug formation, which results in bleeding. 
 
2.2.2 Type 2M VWD 
 
Figure 2.3:  Platelet response at sites of vascular injury while type 2M VWD mutations are present in 
the vWF molecule.  As with the normal case in Figure 2.1, when a vascular injury occurs, the 
subendothelial matrix beneath endothelial cells becomes exposed.  Platelets in the bulk flow do not 
interact with soluble vWF.  However, they also are less likely to tether to the matrix bound vWF via 
their GPIbα receptors.  Because platelets are less likely to bind matrix bound vWF, they are unable 
to tether at sites of injury.  The result is that there are fewer platelets available to initiate rolling 





Mutations causing type 2M VWD result in enhanced bond dissociation and increased 
rolling velocities.  Further, these mutations are defined as LOF because they display 
reduced ristocetin induced binding.  The G561S type 2M mutant displays decreased 
ristocetin binding and normal multimer number, formation, and pattern [6].  Further, this 
mutation may prevent a conformational change in the vWF molecule that reveals the 
GPIbα binding site [7].  Here, in Figure 2.3, we model the binding behavior for platelet 
interactions with vWF carrying LOF type 2M VWD mutations.   Because of the 
decreased binding affinity, there are fewer platelets that will make bonds at the site of 
vascular injury.  Because fewer platelets make successful interactions at the site of 
vascular injury, the site heals more slowly than normal and the patient bleeds.   
 
2.3 Platelet-Type von Willebrand Disease 
Mutations in platelet GPIbα have also been observed that result in  bleeding similar to 
that seen in patients with type 2B VWD.  When the mutation is in platelets, the diseased 
is called pt-VWD.  Theses mutations result in increased binding between vWF and 
platelet GPIbα as is the case for type 2B VWD.  The binding mechanism underlying 
patient bleeding is thought to be similar to that seen for type 2B VWD [14] and is 
modeled here in Figure 2.4. 
 
2.4 Bernard Soulier Syndrome 
Bernard Soulier Syndrome results from defects in the GPIbα molecule that result in 
decreased adhesion between platelets and vWF.  This disease is characterized by 
increased bleeding time, lack of ristocetin induced platelet aggregation, a decreased 
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number of platelets, enlarged platelets, and thrombocytopenia.  Further, it has been 
observed that some variants have normal levels of defective GPIbα present leading to 
decreased binding to vWF, while other variants have decreased levels of GPIbα 









Matrix Bound vWF 
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Figure 2.4:  Platelet response at sites of vascular injury while platelet type VWD mutations are 
present in the GPIbα molecule.  As with the normal case in Figure 2.1, when a vascular injury 
occurs, the subendothelial matrix beneath endothelial cells becomes exposed.  Platelets in the bulk 
flow interact with soluble vWF rather than tethering to the matrix bound vWF via their GPIbα 
receptors.  Because platelets are sequestered in these platelet/vWF aggregates, they are unable to 
tether at sites of injury.  The result is that there are fewer platelets available to initiate rolling 
interactions at the injury site, resulting is delayed hemostatic plug formation, which results in 
bleeding. 
 
2.5 Parallel Plate Flow Chamber Model System 
Parallel plate flow chambers are a common in vitro method for studying the effects of 
steady, laminar fluid shear stress on the interactions between two adhesion molecules.  In 
flow chamber experiments, cells expressing either the receptor or its ligand are typically 
perfused through a parallel plate flow chamber across the respective ligand or receptor 
coated surface.  In these experiments data taken include rolling velocities, tether rate, and 
pause times.  Additionally, flow chamber systems can be used to determine kinetic 
bonding parameters by measuring transient tethering lifetimes and tethering frequency.  
13 
 
The transient tether lifetime is used to measure the off-rate, while the tethering frequency 
is used to measure indicate changes in the on-rate [16].  Pause time analysis is used to 
determine the kinetic off-rate.  In this technique the ligand is coated at a density such that 
only individual tethering events can occur – i.e., too low a ligand coating density for 
rolling to occur.  To obtain the off-rate, the tether distribution data is fit to a first order 
kinetics equation [16]. 
dNb = -koffNb (Equation 1) 
Nb is the number of cells remaining tethered  
koff  = off-rate, negative of the slope  
In addition to pause time analysis to determine off-rates, tethering frequency is used 
to measure kinetic on-rate indicators, and, more specifically, the number of tethering 
event within a given time frame.  These techniques have been used to observe the kinetics 
in many adhesion molecule systems: P-selectin glycoprotein ligand-1 (PSGL-1)-L-
selectin [17], PSGL-1-P-selectin [18], neutrophils-P-selectin [19], neutrophils-E-selectin 
[19], neutrophils-L-selectin [19], and GPIbα-vWF [16, 20, 21].   
The parallel plate flow chamber system has been used by several researchers to 
observe GPIbα-vWF interactions.  Using a parallel plate flow chamber apparatus, 
Doggett and co-workers first showed that the GPIbα-vWF bond for platelets interacting 
with GOF I546V vWF-A1 had a decreased off-rate compared to wt vWF-A1 [21], which 
contradicted previous biochemical assay data by Miura and colleagues that showed an 
increase in on-rate was responsible for enhanced adhesion [22]. Later, Doggett et al. 
showed that interactions between GOF GPIbα and wt vWF were due to both an increased 
on-rate and a decreased off-rate [23].  This trend, where on-rate increases and off-rate 
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decreases, was also shown by Kumar and co-workers using CHO cells expressing GPIbα 
or CHO cells expressing GOF mutant GPIbα rolling on wt vWF-A1 [16].   
 
2.6 vWF and GPIbα Molecules: Function and Structure 
2.6.1 The vWF Molecule 
Platelet adhesion and aggregation are mediated by vWF and GPIbα of the platelet 
GPIb-IX-V complex.  VWF is the largest soluble protein found in the plasma and as a 
soluble plasma protein, vWF does not interact with platelets.  VWF is also found in  α-
granules of platelets and subendothelial matrices [24].  At high shear stress vWF binds to 
exposed subendothelial matrix materials and functions to bridge exposed subendothelial 
collagens and circulating platelets.  It has been suggested that exposure to high shear 
stress upon binding to collagen results in a conformational change in the vWF subunit, 
resulting in a form of vWF that is active and able to form functional interactions with 
platelets [25].   
VWF is a multimeric glycoprotein consisting of a repeating vWF dimer with a 
molecular weight of 500 kDa [26].  The vWF molecule found in the plasma is a globular 
protein, and is a multimer of the vWF dimer [27] with a molecular weight ranging from 
500 to 20,000 kDa [28].  Plasma vWF is predominately high molecular weight multimers 
[29].  A single vWF monomer contains 2,050 amino acids and consists of 11 domains:  
D’-D3-A1-A2-A3-D4-B1-B2-B3-C1-C2.  The mature subunit is decorated with 12 N-
linked and 10 O-linked carbohydrates [30].  The function of N-linked and O-linked 
oligosaccharides on vWF remains unclear.  Some studies have indicated that these 
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carbohydrate chains are responsible for enhanced platelet aggregation [31], while other 
studies have shown these chains to have an inhibitory role in GPIbα aggregation [32].  
Each of the domains within the vWF subunit has distinctive activities.  Factor 
VIII, a protein involved in the clotting cascade, binds vWF at the N-terminal D domains 
[33].  The A1 domain has been shown to be the binding site for GPIbα in the GPIb-IX-V 
complex [24], non-fibrillar collagen type IV [34], collagen type I [7, 35], collagen type 
III [7, 35], heparin [36], ristocetin, botrocetin, and bitiscetin [37].  The A3 domain is the 
binding site for fibrillar collagens types I [38] and III [39].  Ristocetin is an antibiotic 
which is often used in vitro to study platelet agglutination [40].  Botrocetin and bitiscetin 
are two snake venoms which induce platelet agglutination via interactions with vWF.  
Crystal structures for both the A1 and A3 domains have been elucidated to obtain a better 
understanding of these binding sites [39, 41, 42].  Finally, the vWF-C1 domain contains 
an RGD binding site, to which platelet integrin αIIbβ3 has been shown to bind [43].   
 
Figure 2.5: Platelet GPIbα and vWF-A1 crystal structures: isolated vWF-A1 domain [39] (A) and the 
N-terminus of GPIbα [27] (B). 
 
BA 
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As can be seen in Figure 2.5A [39], the A1 domain of vWF consists of a central 
hydrophobic parallel β-sheet flanked by amphipathic helices, containing 7 helices and 6 
strands [39].  A disulfide bond constrains this domain into a globular structure by linking 
the C-terminal and N-terminal regions [27, 39] at Cys509-Cys695 [39].  Short extensions 
which protrude away from the globular structure are formed on the surface containing the 
N- and C-termini.  It is on this surface that all type IIb VWD mutations are clustered [39].   
In soluble vWF, multimers are in a coiled conformation that shields the A1 domain [25].  
However, when the A1 domain is bound to GPIbα the N-terminal extension is shifted in 
a way which reveals more of the surface of the globular domain [27].   It has been 
suggested that the β1-α2 loop in the vWF-A1 molecule is largely responsible for changes 
in interactions between GPIbα and vWF [8].   
 
2.6.2 The GPIbα Molecule 
The receptor for the vWF ligand is found in the GPIb-IX-V complex on platelets.  
This complex consists of four transmembrane polypeptides, GPIbα, GPIbβ, GPIX, and 
GPV.  The complex contains two of each of GPIbα, GPIbβ, and GPIX arranged 
symmetrically around one GPV, with a disulfide bond between the α and β subunits 
(reviewed by López [44]).  It has been shown that vWF binds to the GPIbα subunit in the 
GPIb-IX-V complex [45].  GP1bα is a highly glycosylated transmembrane protein, which 
has been implicated in binding to vWF [46, 47], MAC-1 [48], α-thrombin [49], and P-
selectin [50].   
GP1bα protrudes from the platelet surface via a highly glycosylated stalk 
extending approximately 45 nm from the cell surface [51].  This stalk, from residues 303 
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to 485, has O-linked carbohydrates attached to almost every third or fourth residue and is 
followed by a hydrophobic transmembrane domain from residues 486 to 514 and a 
cytoplasmic tail from residues 515 to 610.  This cytoplasmic tail contains binding sites 
for both intracellular signaling molecules and actin binding proteins [52, 53].  GP1bα 
mutants with truncated cytoplasmic tails rolled faster than wild type [54], indicating the 
cytoplasmic tail is important not only for signaling but also in modulating cell rolling 
behavior. This implicates GP1bα as not only a cell adhesion molecule, but also as a 
molecule involved in signaling and cell structure.   
The crystal structure of the N-terminus of the complete GP1bα molecule has been 
determined (residues 1-279) (Figure 2.5B) [55].  This region of GP1bα consists of an N-
terminal β-hairpin (residues 2 – 18), 8 leucine rich repeats (LRRs), (residues 19 – 204), a 
disulfide bonded loop region (residues 205 -264), and a C-terminal anionic region 
(residues 265 – 280) [55].  The N-terminus of GP1bα is composed of two disulfide loop 
structures [15] flanking 8 LRRs  [27]. Within the disulfide loop region residues 227 – 241 
form a β-switch [27], which protrudes outward from the concave face formed by residues 
1 – 279 [55].  At the base of this N-terminal region lie three sulfated residues [56], which 
are required for binding to both vWF and α-thrombin [57-59].  Tait et al. showed that the 
residues surrounding these tyrosines are important factors for sulfation [60].  This region 
is followed by a series of negatively charged residues from residue 282 to 302.   
Crystal structures suggest that the β-switch (cystine loop) and β-finger (N-terminus) 
strands of GPIbα bind directly to vWF-A1.  Upon binding to vWF-A1, the region 
between residues 227 and 241 at the C-terminus of the GPIbα fragment undergoes a 
conformational change [27].  Many pt-VWD mutations are found in the β-switch region 
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of the GPIbα molecule, while LOF, Bernard-Soulier mutations are found in the LRR 
region [27, 55].  VWF-A1 mutations located on the A1 molecule’s surface containing its 
N- and C-termini align with the N-terminal β-finger residues in the GPIbα molecule [27]. 
 
2.7 Role of ADAMTS-13 
ADAMTS-13 is a protease present in the plasma that cleaves ultra large forms of the 
vWF molecule at its A2 domain between residues Y1605 and M1606 [61].  Ultra large 
forms of vWF are secreted by endothelial cell Weibel Palade bodies onto the endothelial 
surface where they undergo a conformational change and become elongated due to 
conditions of high shear stress.  In their elongated forms the A2 domain is exposed, 
allowing the ADAMTS-13 enzyme to cleave the ultra large form of vWF into smaller 
forms, which are then released from the surface and become soluble vWF [25, 62, 63].   
Further, when soluble vWF binds at sites of vascular injury, it is subjected to high shear 
stresses causing it to unfold revealing both the A1 and A2 domains.  It is thought that the 
ADAMTS-13 protease plays a role in regulating thrombus formation during the injury 
repair by cleaving vWF at its exposed A2 domain preventing the thrombus from 
becoming too large [64].  Defects in ADAMTS-13 result in patients who have ultra large 
forms of vWF circulating in the plasma.  The presence of these large vWF forms results 
in thrombus formation and is seen in thrombotic thrombocytopenic purpura (TTP) [65].    
 
2.8 Biomechanics of Interactions Between Adhesion Molecules Under Flow 
Blood cell adhesion molecules interact while subjected to fluid flow applied forces. 
These types of interactions have been studied using parallel plate flow chambers and 
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several important observations for these adhesive interactions under flow have been 
made.  Of particular relevance to the work presented in this dissertation are the shear 
threshold phenomena, the observation of catch bonds, and the need for high-speed video 
microscopy.  Each topic is discussed in greater detail in this section.   
 
2.8.1 Shear Threshold 
While measuring rolling velocities, several researchers have observed that at very 
low shear rate values there appears to be no rolling.  However, as the shear rate is 
increased, rolling begins.  This concept has been termed the shear threshold phenomena 
because a threshold level of shear rate is required in these systems to promote rolling, and 
hence, any subsequent adhesive events.  This shear threshold concept has been shown for 
several systems, beginning with those involving L-selectin interacting with both 
neutrophils and T-lymphocytes.  Neutrophils and T-lymphocytes were rolled across 
peripheral node addressin (PNAd - a surface containing L-selectin) and it was shown that 
as shear rate was decreased there was a decrease in rolling velocity to no rolling at a non-
zero shear rate value, indicating that the cells required a threshold level of shear rate in 
order to roll.  However, unlike the L-selectin surface, a shear threshold for P- and E- 
selectin were not seen in this research [66], but later work by Lawrence et al. showed a 
threshold for all three selectins:  P-, E-, and L-selectin [67].  It has been shown that 
selectins bearing single mutations in either the hinge region between L-selectin’s lectin 
and EGF domains have a reduced shear threshold [68], while mutations in the ligand 
binding surface of the L-selectin molecule result in elimination of the shear threshold 
requirement [69].  It has been shown that GPIbα expressed on the platelet surface rolls on 
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vWF exposed during vascular damage only above a threshold value of shear rate [21], 
which corresponds to arterial flow rates [21, 70].  Further it was shown that this shear 
threshold was lost for platelet interactions with GOF I546V vWF-A1 mutant [21].  More 
recently the shear threshold phenomena has also been observed in bacteria.  Here it was 
seen that the FimH molecule found on E. coli bacteria rolls on mannose only above a 
shear threshold [71, 72].  Recently the shear threshold concept has been linked to that of a 
transition point in systems where a catch bond exists for interactions with selectins and 
their ligands.  In these systems, this optimum threshold occurs when increasing shear 
force results in a switch from increasing bond lifetimes to decreasing bond lifetimes [17]. 
There are two prevailing hypotheses that have been developed to explain these 
physiological observations that there is a shear threshold.  One hypothesis thought to 
explain the shear threshold phenomenon is that bond formation is enhanced by a flow-
dependent increase in the on-rate [73, 74], while the second hypothesis is that catch 
bonds exist, which slow the dissociation rate [17, 18, 75].  In the first hypothesis, there 
are two theories.  One is that bond formation is enhanced by a flow-dependent increase in 
the on-rate due to a shear rate dependent transport of adhesion molecules to their ligands 
so that new bonds can form before old ones are able to dissociate [73, 74].  The other 
theory is that bond formation is enhanced by a flow-dependent increase in the on-rate due 
to shear stress dependent increase in the cell surface contact area, which would allow 
more adhesion molecules to come into contact with each other [67, 76, 77].  In the second 
hypothesis, a catch bond forms, the off-rate decreases, resulting in an increase in the bond 
lifetimes, which further results in stable rolling [17, 18].  Yago et al. are the first to 
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suggest that catch bonds are the mechanism for the shear threshold phenomenon based on 
experimental observations [17].  
 
2.8.2 Catch Bonds 
Since the theoretical prediction of catch bonds by Dembo et al. [75], many 
researchers have sought examples of catch bonds in biological systems.  The first system 
in which catch bonds were observed was that of P-selectin and PSGL-1 [18].  Atomic 
force microscopy (AFM) and flow chamber experiments were used to explore P-selectin-
PSGL-1 binding through bond lifetimes.  Marshall and colleagues observed that the bond 
lifetime is first decreased by increasing force, but subsequently bond lifetime is increased 
with increasing force.  This work not only is the first to show catch bond behavior with 
biological molecules, but it also shows that there exists a catch-slip transition force 
suggesting a mechanism for regulation of cell adhesion.  Additionally, their data suggests 
that the transition from catch bonds to slips bonds governs rolling velocity across the 
shear threshold.  They conclude that the role of the catch bond is to convert weak tethers 
to strong ones, enabling longer bond lifetimes.   
In addition to P-selectin, another selectin family member, L-selectin, has been 
shown to adhere using catch bonds [78].  Again, for these experiments, AFM and flow 
chamber experiments were used.  This work suggests that the catch bond mechanism 
contributes to the shear threshold phenomenon because catch bonds were observed below 
the threshold, while slip bonds were observed above the threshold.  Here catch bonds are 
defined as a decrease in the off rate and slip bonds are defined as an increase in the off 
rate, as also described by Dembo et al. [75].   
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Another system in which catch bonds are thought to exist is that of FimH on E. 
coli binding to guinea pig red blood cells as a test of adhesion [71, 79].  The FimH 
molecule is located on the tips of the appendages of the bacteria’s pili and binds to 
manomannose residues.  It was observed that FimH found on uropathogenic E. coli was 
able to bind manomannose residues under static conditions, whereas, this binding is seen 
rarely in intestinal E. coli.  Instead, intestinal E. coli adhesion via FimH has been seen to 
be enhanced by mucosal flow (shear flow), such as that seen in the selectin family [71].  
Additionally, Thomas et al. have observed a decrease in the off-rate of the adhesion of 
FimH when external shear stress was applied [71], which is suggestive of catch bond 
behavior [79].   
Additionally, one research group has observed a catch bond like conformational 
change in a system in which standard biomechanical methods have not been used to 
elucidate the presence of catch bonds [80].  Here, FRET (fluorescence resonance energy 
transfer) is used to observe the structural transformation in the integrin α4 in response to 
stimulation using divalent cations and cells.  It was seen that there was a vertical 
extension in the integrin, suggesting a conformational change.  Concurrently there was 
seen a change in binding affinity.  These results taken together suggest a mechanism to 
explain the catch bond phenomenon.   
 
2.8.3 High-speed Video Microscopy 
It is thought that the use of high-speed video microscopy will give a more 
accurate description of the binding kinetics seen in adhesion molecule pairs.  Indeed, 
Smith et al. suggest that the rolling steps are so close together that distinctions cannot be 
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seen between them, resulting in a false sense of the true measure of the kinetics [19]. The 
rationale for a higher speed is that it increases the temporal resolution, hence increasing 
the chance of observing binding events occurring faster than 30 frames per second (fps), 
which is the standard frame rate used by researchers. In these experiments higher 
temporal resolution was used to determine the kinetic off-rate as determined by parallel-
plate flow chamber analyses.  Binding kinetics of P-selectin, E-selectin, and L-selectin 
rolling on neutrophils were measured.  A comparison between high-speed video 
microscopy results (obtained at up to 240 fps) with those measured using the traditional 
30 fps showed that higher temporal resolution made a difference in the interactions 
observed for L-selectin binding.  In contrast, the values obtained were similar for both 
240 fps and 30 fps for P-selectin and E-selectin, suggesting that a greater frame rate may 
be important during observations of some interactions, though not all.  Several other 
researchers have also used high-speed video microscopy in order to observe the kinetics 
between adhesion molecules.  Yago and co-workers used this technique to observe the 
kinetics of L-selectin binding to PSGL-1 [17].  They use this higher temporal resolution 
technique to show that the catch bond is responsible for the shear threshold phenomenon. 
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CHAPTER 3: METHODS 
 
 
3.1 Proteins and Antibodies 
Recombinant vWF A1 molecules (wt, R687E, and G561S) and wt vWF-A1A2A3 
molecules were produced as previously described [7, 81, 82].  Whole vWF was 
purchased from Calbiochem (San Diego, CA).  FITC labeled human anti-GPIbα clone 
AK2 was purchased from Abcam (Cambridge, MA).  FITC labeled calibration beads 
were purchased from Bangs Laboratories, Inc. (Fishers, IN). 
 
3.2 CHO Cells Expressing GPIbα  
Chinese Hamster Ovary (CHO) cells expressing wt GPIbα were produced as 
previously described [83].  These cell lines allow for the observation of the isolated 
GPIbα receptor and can be used to confirm GPIbα’s role in the platelet interactions 
studied, because platelets have several molecules, including integrins, that may interact 
with vWF.  Further, CHO cells were used for expression of GPIbα because they are 
robust cells that are easily transfected and cultured.  Further, these cells are essentially 
spherical and allow for direct correlations with mathematical models and equations that 
assume spherical particles.  CHO cells were cultured in α-MEM (Mediatech, Inc., 
Manassas, VA) containing 10% FBS (Hyclone, Logan, UT) and penicillin (5,000 
units/mL)/streptomyocin (5,000 μg/mL) (Cellgro, Manassas, VA).  Medium for all CHO 
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cell lines was supplemented with selection agents G418 (400 μg/mL, Invitrogen, 
Carlsbad, CA) and methotrexate (80 μM, Sigma, St. Louis, MO).  Media for CHO cells 
expressing the GPIbα receptor (wt or mutant) was also supplemented with 400 μg/mL 
Hygromyocin B (Invitrogen, Carlsbad, CA). All cell lines were maintained at 37oC in 5% 
CO2, 95% air.  
 
3.3 Platelet Isolation 
Platelets were isolated from whole blood drawn from healthy volunteers according to 
an approved Institutional Review Board procedure, in which all volunteers gave written, 
informed consent.  Platelet rich plasma was isolated from fresh whole blood and drawn 
into citrate buffer (25 g sodium citrate, 8 g citric acid, 500 ml H2O) containing 2 μM 
prostaglandin E-1.  Whole blood was centrifuged at 150g for 15 minutes at room 
temperature.  The supernatant, platelet rich plasma, was removed and mixed with acid 
citrate dextrose (6.25 g sodium citrate·2 H2O, 3.1 g citric acid anhydrous, 3.4 g D-glucose 
in 250 ml H2O), 10% by volume, and centrifuged at 900g for 5 minutes at room 
temperature.  The pellet was suspended in Hepes-Tyrode buffer and diluted to 1x108 
platelets per mL in Hepes-Tyrode buffer for flow assays.   
 
3.4 Measurement of Viscosity 
Viscosity of platelet suspension buffer was measured using an Ostwald dripping 
viscometer as previously described [17] and at 37oC.  Buffer alone and buffer plus 6% 
Ficoll were added to the reservoir of an Ostwald dripping viscometer.  The time taken for 
the fluid to fall from the top of the capillary bulb to the bottom was measured.  Density 
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for Ficoll was provided by the manufacturer at 1.02 g/mL for 6% Ficoll.  The viscosity of 


























μ = viscosity of fluid 
Δt = time for fluid drop in viscometer capillary bulb 
ρ = density of fluid 
In some experiments 6% Ficoll (MW 400, Sigma) (w/v) was added to increase the 
viscosity 1.8 times compared to buffer alone.   
 
3.5 Preparation of vWF Molecule Coated Surfaces 
The flow chamber surface was a 35 mm tissue culture dish coated with vWF A1 
molecules (wt at 100 μg/mL, R687E at 100 μg/mL, or G561S at 200 μg/mL), wt vWF 
A1A2A3 (at 100 μg/mL), or whole vWF molecules (at 50 μg/mL).  A 20 μL drop of 
vWF molecule was coated onto the dish and incubated overnight at 4oC.  The surface was 
rinsed with PBS and blocked with 20 μL of 1% HSA for 2 hours at room temperature, 
then the surface was again rinsed with PBS.  The prepared dish was used as the lower 
surface for the flow chamber and brought to 37oC prior to starting the experiment.   
 
3.6 vWF-A1 Site Density Measurements 
The site density (number of vWF-A1 sites per μm2) of vWF-A1 molecules was 
determined using an ELISA previously described [16].  VWF-A1 molecules were coated 
onto the surface of a 96-well tissue culture plate.  Horseradish peroxidase (HRP)-
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conjugated 6-his-tag antibody was used to detect the 6-his-tag attached to the 
recombinant vWF-A1 molecules.  HRP absorbance was measured at 490 nm and was that 
of o-phenylenediamine/H2O2.  A calibration standard was used to quantify the number of 
sites per unit area.   
 
3.7 Flow Cytometry for GPIbα-Receptor Expression on CHO Cells and Platelets 
Surface expression of the GPIbα receptor on platelets was determined using a 
primary conjugated antibody to GPIbα. The antibody is specific for the N-terminus of the 
GPIbα molecule, clone AN51 or clone AK2 [28].  Calibration beads (Bangs Labs, Inc.) 
were used to zero the flow cytometer voltage settings, such that the blank bead 
population is at the origin of the mean fluorescence intensity vs. count graph.  The mean 
fluorescent intensity of each bead population was then measured and the number of 
receptors per surface area was calculated using the calibration beads.  
 
Figure 3.1: GPIbα expression on platelets as assessed by flow cytometry.  Platelets were labeled with 
and without primary RPE-conjugated GPIbα antibody (clone AK2).  Platelets without antibody 
showed background low fluorescent values, while platelets with antibody showed a significantly 
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Figure 3.1 shows representative histograms for platelets with and without antibody and 
indicates that we are able to detect the GPIbα receptors on platelet samples.  Platelets 
without antibody were used as a control.  Platelets were counted and sized using a 
Coulter Counter. The average diameter from this method was used to determine the 
surface area of the platelet sample, which was used to calculate the number of receptors 
per surface area of cell.   
Surface expression of the GPIbα receptor expressed on CHO cells was also 
determined using the same primary conjugated antibody to GPIbα as was used for 
platelet GPIbα expression levels.  
 
Figure 3.2: Flow cytometry for GPIbα expression on CHO αβ9 cells. CHO β9 or CHO αβ9 cells were 
labeled with or without primary conjugated FITC-AN51 GPIbα antibody.  CHO β9 cells without 
antibody, CHO β9 cells with antibody, and CHO αβ9 cells without antibody showed background low 
fluorescent values, while CHO αβ9 cells with antibody showed a significantly increased fluorescent 
value.   These results indicate that the GPIbα molecule is present on CHO αβ9 cells and not on 




 CHO cells were suspended in PBS at a concentration of 0.5 x 106 cells/mL.  CHO αβ9 
cells were incubated for 30 minutes with a primary conjugated GPIbα antibody.  Three 
control populations were used, all of which resulted in mean fluorescent values near zero:  
CHO β9 cells without antibody, CHO β9 cells with antibody, and CHO αβ9 cells without 
antibody.  Figure 3.2 shows an example set of flow cytometry histograms where GPIbα 
receptors were labeled with a FITC labeled primary conjugated antibody directed to the 
AN51 clone site on GPIbα.  Here it is clear that CHO αβ9 have the GPIbα receptor 
present, while CHO β9 and unlabeled controls show only background fluorescence.   
 
3.8 Flow Cytometry Cell Sorting to Maintain Receptor Cell Surface Expression 
Flow cytometry was used as described above to maintain the surface expression of 
GPIbα on CHO cells in order to ensure that multiple experiments using CHO cells may 
be combined and/or compared.  Calibration beads from Bangs Labs, Inc. were used to 
determine the number of receptors per surface area for CHO αβ9 cells, which were sorted 
using either the FITC-AN51 antibody or the RPE-AK2 antibody, to maintain an 
expression level similar to that seen on the platelet surface measured as number of 
receptors per μm2 [16].  
 
3.9 Flow Chamber Assay 
A parallel platelet flow chamber (GlycoTech, Gaithersberg, MD) was used to apply 
shear stress to platelets interacting with a vWF coated surface.   Cells (CHO β9 or CHO 
αβ9) or platelets were perfused through the flow chamber with a syringe pump (Harvard 
Apparatus, Holliston, MA).  Figure 3.3 shows this flow chamber set up.  Interactions 
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were visualized using an inverted-stage phase-contrast microscope (DIAPHOT-TMD; X-
20 or X-10 phase objective and X-5 projection lens, Nikon, Garden City, NY).  The flow 
chamber was maintained at 37oC using an air curtain surrounding the microscope.  
Images were captured at 250 fps directly to a computer using a high-speed video camera 















Figure 3.3: Parallel plate flow chamber system.  Platelets or CHO cells expressing GPIbα are 
perfused across a vWF coated surface.  Cells recorded are observed in multiple fluid layers and are 
classified as cells interacting at the lower (vWF molecule coated) surface and cells that are not 
interacting in the bulk flow.  
 
Images were analyzed post-experiment using the Track Object module in Metamorph 
Offline software (Molecular Devices, Sunnyvale, CA).  Further data analysis, plot 
generation, and statistics were completed using a Matlab analysis program written 
specifically for analysis of this data.  For this analysis, the position for each frame was 
determined during data collection when cells were tracked.  This position was used 
directly to determine velocity for each frame as distance per time.  Lower bounds for 
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rolling velocities were determined by tracking cells that were stopped in each video.  The 
velocity associated with these cells was then subtracted from cells that were rolling to 
determine the velocities for rolling cells.  For rolling parameter analysis, position and 
time data for each frame were used as inputs into the stop-go model described previously 
[17] and discussed here in Methods Section 3.13. 
 
3.10 Flow Chamber Experimental Controls 
The control coverslip was coated with 1% HSA.  In experiments where CHO cells are 
used, CHO β9 cells, which do not express the GPIbα receptor, will serve as control for 
CHO αβ9 cells.  Table 3.1 shows the components of CHO cell lines used.   
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3.11 High-speed Video Microscopy 
Interactions of CHO cells or platelets interacting with vWF-A1 coated coverslips 
were recorded at 250 fps using a high-speed video camera.  To determine if 250 fps was 
the optimal frame rate for the GPIbα-vWF interaction, frame rates ranging 100 to 500 fps 
were tested.  The optimal frame rate (here 250 fps) was chosen such that rolling velocity 





3.12 Treatment with ADAMTS-13 Enzyme 
For experiments conducted in the presence of ADAMTS-13, the procedure is similar 
to that for other flow chamber experiments as described in section 3.9.  For these studies 
whole vWF was coated on the 35 mm tissue culture dish overnight at 4oC.  The next day 
the dish was rinsed with PBS and coated with 1% HSA for 3 hours at 4oC.  The dish was 
again rinsed with PBS and the ADAMTS-13 enzyme (5 μg/mL) was coated on the whole 
vWF coated surface for 30 minutes at room temperature.  The dish was then used as the 
bottom of the flow chamber assembly and platelets were perfused through the flow 
chamber and the transient tethering interactions recorded for analysis.    
 
3.13 Measurement of Rolling Velocities and Rolling Step Parameters 
Rolling velocities were calculated as the total distance traveled in a one second 
interval.  Each velocity represents an average of tens to hundreds of cells.  Rolling step 
parameters were determined as described [17] from video taken at 250 fps.  In these 
studies rolling interactions were studied to gain insight into bonding behavior.   
It has been established that cell rolling is predominately mediated by the dissociation 
rate of the bonds formed and broken during rolling motions [17, 21, 84].  Bond 
dissociation occurs because of the fluid force applied to the bond and is used to determine 
bond lifetime, which is inversely proportional to the dissociation rate.    Because of these 
observations, when we observe a decrease in rolling velocity, it is reasonable that such an 
observation would suggest that the bond lifetime is increasing or that the dissociation rate 
is decreasing, which is indicative of a catch bond.  These changes in bonding would 
result in a longer lived bond, which likely explains why the cell rolls more slowly.  
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Conversely, when the cell rolling velocity increases with increasing shear stress, it likely 
indicates that the bond lifetime is decreasing, or that the dissociation rate is increasing, 
which is indicative of a slip bond.  For the purposes of the data presented in this 
dissertation, the term catch-slip is used to describe indirect bonding measurements of 
rolling interactions where it is likely that catch and slip bonds are present, rather than to 
indicate that catch and slip bonds were directly measured.   
To further investigate rolling interactions, a more detailed analysis was conducted 
using the stop-go model for measurement of rolling step parameters, which is shown in 
Figure 3.4.   
 
Figure 3.4: Rolling step parameter model from Yago et al. [17].  As a cell rolls on a surface, the shear 
force and torque generated by the fluid flow are counteracted by tensile and compressive forces.  If 
these forces equally balance, the cell will stop.  Otherwise, the cell can accelerate or decelerate 
depending on which set of forces dominates the rolling interaction for a given step.  A frame-by-
frame analysis was conducted and each frame was labeled as stopped, pivoting, or stretching.       
 
Stop-Go analysis using this model has previously been used to describe the behavior of 
cells rolling on a ligand coated surface [17].  In this model, shear stress applied in a flow 
chamber results in shear force and shear torque applied to flowing and interacting cells.  
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When a cell tethers these parameters are balanced by a tensile force (trailing edge of the 
cell) and by a compressive force (due to contact area at the cell-surface interface).  In 
order for cells to stop, the bond formed between the flowing cell and the stationary 
surface must be able to withstand the maximum values of shear force and shear torque.  If 
this balance occurs the cell will stop.  When this bond breaks the cell will accelerate, and 
as it does so, it will pivot in the direction of forward motion.  Next, the cell will either 
stop again (if the balance of force and torques is met) or it will continue to accelerate.  If 
a new upstream bond is formed the cell will decelerate.  At each stage the cell may 
accelerate, decelerate, or stop depending on the amount of force a given bond provides to 
balance the shear force and shear torque.  Based on these observations, a cell’s motion for 
a given frame is characterized as a stop, pivot, or stretch and the time for each parameter 
is calculated.   
 
3.14 Calculation of Transient Tethering Lifetimes 
The bond lifetimes were calculated from transient tethering flow chamber data.  Cells 
were observed and the time from when the cell stopped until the time where it returned to 
free flow was measured.  These times were then used to generate a plot of the ln (# 
bound) versus the time the cell spent stopped.  Figure 3.5 shows a representative plot.  
This type of plot was made for a single shear stress.  The slope of the line is the kinetic 
dissociation rate, or off-rate, for the interactions.  Further, the bond lifetime is inversely 





Figure 3.5: Determination of bond off-rates and calculation of bond lifetimes.  Here an example set of 
cells at a single shear stress are shown to represent the calculation of off-rate.  The number of cells 
bound was plotted versus the duration of the bond.  The kinetic off-rate is slope of the line and the 
bond lifetime is the inverse of the off-rate.   
 
 
3.15 Calculation of Shear Stress and Bond Force 
The force on a bond under fluid shear stress can be converted into shear stress using 
the Goldman equations [1] and force and torque balances [16, 21, 84, 85].  First, the shear 
force formula from the Goldman equations is used to calculate shear force [1]: 
ARhFS γπμ6=  (Equation 3) 
Parameters and constants in these equations are as follows:  
μ = viscosity (poise) 
R = cell diameter (μm) 
h = distance from the center of the cell to the wall (μm) 
γ = shear rate (s-1) 
A = Constant determined from Table I (a = R, h = h ) in [1] 
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For this calculation, it is assumed that h/a approaches 1, so that A = 1.7005.  Next, 
the resulting value from equation 3 is used in the following force and torque balances, 
respectively:  
θcosbS FF =  (Equation 4) 
SSb RFLF +=τθsin  (Equation 5) 
Fb = force on the bond  
τS = shear stress  
θ = the bond angle between the cell and the surface  
L = lever arm (length) 
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CHAPTER 4: GPIBα-VWF WT-WT ROLLING INTERACTIONS UNDER 
SHEAR STRESS ARE REGULATED BY THE CATCH BOND MECHANISM 
WHILE OBSERVATIONS UNDER SHEAR STRESS REVEAL DIFFERENCES 




As described in Chapter 1, activated platelets mediate the homeostatic response to 
vascular injuries.  Evidence suggests clinical similarities in several bleeding disorders, 
yet differences in the bonding mechanics have been seen for interactions between the 
molecules involved in these disorders.  In particular, the interactions between GPIbα and 
vWF are disrupted resulting in patient bleeding for type 2B VWD, type 2M VWD, and 
TTP.  
In type 2B VWD it is believed that platelets form aggregates with the mutant vWF 
molecules in the bulk flow.   Platelets become sequestered in these aggregates and are 
cleared from the blood resulting in mild thrombocytopenia and patient bleeding since the 
platelets are no longer available to interact at sites of vascular injury.  Under normal 
conditions wt-wt catch-slip bond interactions likely prevent platelet aggregate formation 
by preventing increased adhesion between GPIbα and vWF at lower shear stresses [5].  
In type 2M VWD there is decreased affinity between platelets and vWF molecules as 
defined by decreased ristocetin induced binding [6].  There is also evidence suggesting 
these mutations prevent a conformational change in the vWF molecule that would reveal 
the GPIbα binding site [7].  Additionally, there are increased off-rates and rolling 
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velocities for platelet-LOF vWF interactions.  Further, AFM experiments show that LOF 
G561S vWF-A1 binding with GPIbα results in a catch bond, but at higher force [86].  
However, the tether bond behavior of type 2M VWD-causing mutations under conditions 
of flow remains largely unknown.      
To further investigate the mechanics of the tether bond, interactions were captured at 
250 frames per second and a frame-by-frame analysis of these interactions was 
conducted.  The steps in the binding of a single tether were analyzed and characterized in 
stages as either a stop or a go as has been described for selectin rolling interactions [17].  
Here we analyze binding behavior to better understand how the changes seen in mutants 
associated with VWD occur at the tether bond level.  Here it is shown that the rolling 
velocity and bonding behavior provide additional insight into how GPIbα and vWF 
regulate rolling, and it is shown for the first time that platelets rolling on G561S vWF-A1 
molecules retain the catch-slip bond transition for rolling interactions under flow, which 
is consistent with AFM data by Auton et al. [86].   Further, it is shown by looking at the 
mean stop times, that under physiological fluid shear stress, the catch-slip transition for 
wt-GOF vWF-A1 interactions occurs at a lower shear stress than for wt-wt interactions, 
which occurs at a lower shear stress than for wt-LOF vWF-A1 interactions.  Taken 
together, these data provide details of the GPIbα-vWF tether bond and the differences 
that exist between LOF and GOF mutations, and hence between type 2M and 2B VWDs.   
Finally, changes in the GPIbα-vWF tether bond are investigated under conditions that 
mimic TTP.  The experimental set up is similar to that for VWD diseases; however, 
platelet interactions are observed with whole vWF in either the presence or absence of 
ADAMTS-13.  Using these techniques, it is seen that in the absence of ADAMTS-13 
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there are increased bond lifetimes, indicating that there are decreased off-rates.  These 
data suggest a possible reason for aggregate formation with ultra large forms of vWF 
when ADAMTS-13 is absent, resulting in TTP.   
 
4.2 Results 
4.2.1 Rolling Velocities for Platelets Interacting with vWF Molecules  
Platelet rolling velocities were calculated for interactions of platelets with wt 
vWF-A1 (Figure 4.1A), wt vWF-A1A2A3 (Figure 4.1B), or whole vWF (Figure 4.1C).  
The rolling velocity of platelets interacting with wt vWF-A1 first decreases and then 
increases with increasing shear stress (Figure 4.1A).   Further, all wt vWF molecules 
display a catch-slip transition with rolling velocity first decreasing at lower shear stresses, 
followed by transitioning to increasing velocities at higher shear stresses.  Minimum 
rolling velocities were similar for all wt vWF molecules (Figure 4.1).  The catch-slip 
transition occurs for wt vWF-A1 (Figure 4.1A) and whole vWF (Figure 4.1C) at 16 
dyn/cm2, while the transition for wt vWF A1A2A3 (Figure 4.1B) occurs at 8 dyn/cm2.   
 
4.2.2 Rolling Velocities on wt vWF-A1 Domain with Different Fluid Viscosities  
In Figure 4.2, purified platelet rich plasma with or without 6% Ficoll was 
perfused across a wt vWF-A1 coated coverslip (100 μg/mL) at 37oC.  Results were 
plotted against both shear rate (Figure 4.2A) and shear stress (Figure 4.2B).  There is an 
increase in shear stress by a factor of 1.8 at a given shear rate for samples containing 6% 
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Figure 4.1: Rolling velocity of platelets on various forms of wild-type vWF molecule: (A) wt vWF-A1 
(n = 14 to 256), (B) wt vWF-A1A2A3 (n = 10 to 36), or (C) wt whole vWF (n = 44 to 277). Data 
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Figure 4.2: Effects of viscosity on rolling velocity of wt vWF-A1 molecules for (A) shear rate and (B) 
shear stress for platelets rolling on wt vWF-A1.  Data represent the mean ± SEM.  For 0% Ficoll n = 
14 to 256 cells and for 6% Ficoll n = 10 to 112 cells.  Each catch-slip transition is statistically 
significant with a p-value < 0.05. 
 
When rolling velocities were plotted as a function of shear stress, the curves align (Figure 
4.2B).    These results show that rolling interactions depend on the shear stress applied to 
the bond.  Therefore, this data suggests that the bonding mechanism is force, rather than 
transport, dependent, suggesting that bond force governs rolling velocity interactions. 
 
4.2.3 Effects of Viscosity on Mean Stop Times for Platelets Rolling on wt vWF-A1   
In Figure 4.3, purified platelet rich plasma with or without 6% Ficoll was 
perfused across a wt vWF-A1 coated coverslip (100 μg/mL).  Mean stop times were 
plotted against both shear rate (Figure 4.3A) and shear stress (Figure 4.3B). Shear stress is 
increased by a factor of 1.8 at a given shear rate by the addition to the samples of 6% 
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Figure 4.3: Effects of viscosity on mean stop times of wt vWF-A1 molecules: (A) shear rate and (B) 
shear stress for platelets rolling on wt vWF-A1.  Data represent the mean ± SEM.  For 0% Ficoll n = 
14 to 256 cells and for 6% Ficoll n = 10 to 112 cells.  Each catch-slip transition is statistically 
significant with a p-value < 0.05. 
 
The curves do not align when plotted against shear rate (Figure 4.3A), but do align when 
plotted as a function of shear stress (Figure 4.3B).  Together these data suggest a force 
rather than transport dependent bonding mechanism.  Alignment with shear stress 
suggests bond force governs mean stop time interactions. 
 
4.2.4 Effects of Shear Stress on Mean Stop Time and Mean Go Time for Platelets Rolling 
on wt vWF-A1 Molecules   
Purified platelet rich plasma with or without 6% Ficoll was perfused across a wt 
vWF-A1 coated coverslip (100 μg/mL) at 37oC.  The average amount of time a cell spent 
in either the stop or the go phase over a one second interval was calculated from rolling 
data.   Figure 4.4 shows that mean go time is constant when compared to mean stop 
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Figure 4.4: Comparison of mean stop and go times for platelet rolling interactions with wt vWF-A1 
molecule: (A) 0% Ficoll (n = 14 to 256) and (B) 6% Ficoll (n = 10 to 112).   Data represent the mean ± 
SEM.  Each catch-slip transition is statistically significant with a p-value < 0.05. 
 
Furthermore, the mean go time is less than the mean stop time for all shear stresses 
investigated.  These data indicate that the mean go time is unaffected by the shear stress.  
Further, because the biphasic mean stop time has longer durations, the data suggests that 
the mean stop time is a controlling parameter for rolling interactions.   
 
4.2.5 Transient Tethering Lifetime Measurements for Platelets Rolling on wt vWF-A1 
Molecule 
Off-rates were calculated for platelet interactions with wt vWF-A1 molecule.  
Platelets rich plasma was perfused across low density vWF-A1 molecule.  The time a 
platelet spent stopped was measured.  A plot of the ln (# cells bound) versus time bound 
was used to calculate the off-rate for each shear stress as described in the Methods 
section 3.14.  In Figure 4.5 the off-rate first decreases, then increases with increasing 
shear stress.  This data shows the bonds dissociate more rapidly at the lowest shear 
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stresses, less rapidly as shear stress is increased, and then the bonds dissociate more 
rapidly with increasing shear stress.   
 
















Figure 4.5: Transient tethering of platelets on wt vWF-A1 molecule.  Data represent mean ± SEM 
and n = 2 experiments (40 to 94 cells per experiment), except for 16 dyn/cm2 which represents 1 
experiment (104 cells per experiment). 
 
This trend indicates a catch-slip transition for the off-rate between platelets and wt vWF-
A1 molecules.  The relationship here is reciprocal compared to the rolling velocity data 
seen in Figure 4.1A.  Because off-rate is a force dependent parameter, this data also 
suggests that the rolling interactions between platelets and wt vWF-A1 are force 
dependent.   
 
4.2.6 Rolling Velocities of Platelets Interacting with vWF Molecules Containing 
Mutations 
Platelet rolling velocities were calculated for interactions of platelets with GOF 
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Figure 4.6: Rolling velocity of platelets on mutant vWF molecules: (A) GOF R687E vWF-A1 (n = 5 to 
121) and (B) LOF G561S vWF-A1 (n = 23 to 98).  Note that because there is decreased association 
between platelets and LOF G561S vWF-A1 (B), fewer interactions occur at all shear stresses and 
none occur at the highest shear stresses measured for other vWF molecules.  Data represent mean ± 
SEM. Each catch-slip transition is statistically significant with a p-value < 0.05. 
 
Unlike wt vWF molecules (Figure 4.1) and LOF G561S vWF-A1 (Figure 4.6B), all of 
which display a catch-slip transition with rolling velocity first decreasing at lower shear 
stresses, then transitioning to increasing velocities at higher shear stresses, GOF R687E 
vWF-A1 (Figure 4.6A) displays only a slip bond.  Further, minimum rolling velocities 
were similar for LOF G561S vWF-A1 (Figure 4.6B) compared to all wt vWF molecules 
(Figure 4.1).   
 
4.2.7 The Mean Stop Time Catch-Slip Transition Shear Stress Varies Depending on the 
vWF-A1 Molecule 
Interactions of platelets rolling on vWF-A1 molecules were characterized frame-
by-frame as stop or go motions, and rolling interactions were measured at 250 fps.  
Figure 4.7 shows the mean stop time data, which is the average time a cell spends in the 
stop phase during a one second interval.   
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Figure 4.7: Mean stop times of platelets on vWF-A1 molecules:  (A) wt vWF-A1 (n = 14 to 256), (B) 
GOF R687E vWF-A1 (n = 5 to 104), and (C) LOF G561S vWF-A1 (n = 11 to 382).  Data represent 
the mean ± SEM.  Each catch-slip transition is statistically significant with a p-value < 0.05. 
 
For all vWF-A1 molecules, the mean stop time first increases, then decreases as the shear 
stress increases.    The catch-slip transition for GOF R687E vWF-A1 (2 dyn/cm2, Figure 
4.7B) is decreased compared to that of wt vWF-A1 (16 dyn/cm2, Figure 4.7A).  However, 
this transition for LOF G561S vWF-A1 (32 dyn/cm2, Figure 4.7C) is increased compared 




4.2.8 Transient Tethering Lifetimes for Platelets Interacting with LOF G561S vWF-A1 
Off-rates were calculated for platelet interactions with LOF G561S vWF-A1 
molecule (Figure 4.8).  Platelet rich plasma was perfused across low density vWF-A1 
molecule.  The time a platelet spent stopped was measured.   
 



























Figure 4.8: Transient tethering of platelets on LOF G561S vWF-A1 molecule.  Data represent mean 
± SEM and n = 7 experiments (2 to 89 cells per experiment), except for 8 dyn/cm2, which represents 5 
experiments (3 to 30 cells per experiment). 
 
A plot of the ln (# cells bound) versus time bound was used to calculate the off-rate for 
each shear stress as described in the Methods section 3.14.  In Figure 4.8 the off-rate first 
decreases, then increases with increasing shear stress.  This data shows that the bonds 
dissociate more rapidly at the lowest shear stress, less rapidly as shear stress is increased, 
and then the bonds dissociate more rapidly with increasing shear stress.  This trend 
indicates a catch-slip transition for the off-rate between platelets and LOF G561S vWF-
A1 molecules similar to that seen for platelets and wt vWF-A1 molecules.  The 
relationship here is reciprocal compared to the rolling velocity data seen in Figure 4.6B.  
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Because off-rate is a force dependent parameter, this data also suggests that the rolling 
interactions between platelets and LOF G561S vWF-A1 are force dependent.   
 
4.2.9 Tether Rate Analysis for Platelets Interacting with wt or LOF G561S vWF-A1 
In Figure 4.9 the role of on-rate in the GPIbα-vWF tether bond formation was 
investigated.  Platelets were perfused across a vWF-A1 coated surface.  Here the initial 
tethering of cells was observed and quantified as percentage of cells tethered (Figure 
4.9A) and as number of cells tethered per minute (Figure 4.9B).  These data sets are 
preliminary and represent one or two experiments as noted in Figure 4.9.  Here the 
percentage of tethered cells is low for both platelet interactions with wt vWF-A1 and 
LOF G561S vWF-A1 at lowest shear stresses (Figure 4.9A).   
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Figure 4.9:  Tethering frequency of platelet interactions with wt vWF-A1 and LOF G561S vWF-A1 
molecules.  Percentage of platelets tethering to wt or LOF G561S vWF-A1 molecules (A) and the 
number of platelets tethering to wt or LOF G561S vWF-A1 molecules per minute (B).  Data 
represent mean ± SEM and n = 2 experiments, except for LOF G561S vWF-A1 data at 128 dyn/cm2 




However, at the highest shear stresses studied, the percentage tethered for platelet 
interactions with wt vWF-A1 is greater than that for platelet interactions with LOF 
G561S vWF-A1 (Figure 4.9A).  The number of platelets tethering per minute is similar 
for wt vWF-A1 and LOF vWF-A1 (Figure 4.9B), and is increased at the lower shear 
stresses and decreased at the higher shear stresses studied.   These data suggest a reason 
why LOF G561S vWF-A1 interactions may have decreased affinity binding compared to 
wt vWF-A1. 
 
4.2.10 Effect of the Presence of ADAMTS-13 Enzyme on Platelet Interactions with 
Whole vWF 
Platelets were perfused across a low density whole vWF coated surface that either 
was or was not exposed to the enzyme ADAMTS-13.  The transient tethering lifetimes 
were measured for each shear stress and used to calculate the bond lifetimes (Figure 4.10) 
as described in Methods section 3.14.  Data show that in both the presence (Figure 4.10, 
open triangles) and the absence of ADAMTS-13 (Figure 4.10, open squares) the bond 
lifetime is biphasic, suggesting that there is a catch-slip transition for both cases.  Further, 
at lower shear stresses studied the bond lifetimes in the presence of ADAMTS-13 (Figure 
4.10, open triangles) are decreased compared to bond lifetimes calculate in the absence of 
ADAMTS-13 (Figure 4.10, open squares).  These data indicate that when the ADAMTS-






















Figure 4.10: Effect of the presence of ADAMTS-13 on bond lifetime for platelets interacting with 




Analyzing interactions between GPIbα and vWF molecules shows differences 
between wt vWF molecules and vWF molecules with mutations causing type 2M and 2B 
von Willebrand Diseases.  The type 2M mutation used in these studies, G561S, occurs 
naturally, and is characterized by decreased platelet binding in the presence of ristocetin 
(LOF), as well as by a normal multimer pattern and normal number of vWF antigens 
present [6].  The type 2B mutation used in these studies, R687E, is a non-naturally 
occurring mutation with characteristics similar to those seen for naturally occurring type 
2B mutations and is characterized by enhanced platelet binding with ristocetin (GOF) 
[12, 13].   
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Here we show that platelets interacting with wt vWF molecules display biphasic 
rolling velocity, mean stop time, and off-rate profiles (Figures 4.1 through 4.8).  Platelets 
rolling on wt molecules have rolling velocities that first decrease, then increase with 
increasing shear stress (Figure 4.1).  This trend suggests that as the platelets are rolling 
more slowly, the bond is lasting for a longer time, a trend indicative of a catch bond.  
Then, as shear stress is further increased, the rolling velocity increases with increasing 
shear stress, suggesting that the bond is lasting for increasingly shorter times, a trend 
indicative of a slip bond.  Such catch-slip transitions have been previously shown in two 
other biological systems.  Flow enhanced adhesion was shown for both interactions of 
selectins with their respective ligands [17, 18, 78], and interactions between bacterial 
FimH and mannose residues on glycoproteins [72, 87].  
We extend the rolling interactions to observe more detailed motions of the platelets 
rolling on vWF molecules.  First, to further investigate these rolling interactions, the 
mean stop time for platelets interacting with wt vWF-A1 was measured (Figure 4.7).  
Rolling parameters were calculated from frame-by-frame rolling velocity data collected 
at 250 fps.  To quantify these interactions each frame is characterized as a stop or a go 
motion based on whether the cell is accelerating or decelerating in each frame relative to 
the previous frame as described in Methods section 3.13.  These values are reported here 
as mean stop times and mean go times.   Though this type of data does not directly 
measure single bond behavior, it can be used to infer information about bond lifetimes of 
molecules interacting under fluid forces. For platelet-wt vWF-A1 interactions we show 
that the mean stop time first increases and then decreases with increasing shear stress 
(Figure 4.7A).     Because mean stop time indicates the amount of time a cell spends 
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stopped, it is analogous to the bond lifetime.  Therefore, in terms of bond lifetime, this 
data suggest that the bond lifetime is increasing at lower shear stresses with increasing 
shear stress, while it is decreasing as the shear stress is further increased beyond a 
maximum lifetime.  This trend likely indicates regions of catch bonding followed by 
regions of slip bonding as shear stress is increased.  Further, L-selectin coated 
microspheres rolling on a PSGL-1 surface show a similar trend [17].     
We also studied the mean go times for wt-wt rolling interactions, which represent the 
average amount of time the platelets spent moving forward after a stop.  Based on the 
model used [17], the mean go time is the combination of the cell first pivoting forward 
after the previous bond is broken and the cell stretching the new trailing bond as it moves 
forward.  Thus, the observations made here can be used to infer information about the 
rate of association for the tether bond.  The rolling step interactions show that the mean 
go time for wt-wt interactions is constant when compared to the mean stop time for wt-wt 
interactions (Figure 4.4).  Further, the data shows that the mean go time is less than the 
mean stop time for all shear stresses.  Together this data suggest that the mean stop time 
is more responsive than go time for GPIbα-vWF tether bond interactions and is likely the 
controlling parameter in GPIbα-vWF rolling interactions.  Because the stop time suggests 
information about how long a bond lasts (bond lifetime), and go time suggests 
information about how bonds are formed, together these data suggest that the bond 
lifetime regulates wt-wt interactions subjected to fluid shear stress.  Since the mean go 
time is constant relative to the mean stop time, these data suggest that the time spent by 
the cell moving forward would be unaffected by changes in fluid shear stress when 
compared to changes in the time the cell spends stopped.  Further, because the mean stop 
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time suggests changes in the bond lifetime (regulated by force) regulate wt-wt 
interactions, these observations can be extended to suggest that a force mechanism, rather 
than a transport mechanism, regulates the GPIbα-vWF tether bond when subjected to 
fluid shear stress. 
To study the bond lifetime more directly, the transient tethering lifetime for platelets 
interacting with either wt or LOF G561S vWF-A1 was measured under conditions of 
force applied by fluid forces in a parallel plate flow chamber (Figures 4.5 and 4.8).  The 
bond lifetime is calculated from the dissociation rate, or off-rate (koff), for the bond, 
which is inversely proportional to the bond lifetime.  Figures 4.5 ad 4.8 both show a 
decrease in the dissociation rate as shear stress is increased to a minimum value after 
which the dissociation rate increases with further increasing shear stress.  These data are 
consistent with data published by us and our collaborators [5, 86].   
For platelet interactions with wt vWF-A1, we show for mean stop times that 
increasing the viscosity (and force) at a given shear rate, results in curves that align when 
plotted versus shear stress, but do not align when plotted versus shear rate (Figure 4.3).  
These data are consistent with the rolling velocity data presented here (Figure 4.2) and 
previously by us and our colleagues [5], where, when the viscosity is increased for wt-wt 
interactions, the data also aligns when plotted against shear stress, but not shear rate.  The 
mean stop time indicates the average amount of time during a one second interval that the 
cell spends stopped.  This parameter can be used to infer information about bond lifetime 
and off-rate because this type of measurement is an indicator for how long the bond is 
stopped before the platelet moves again.  The data, therefore, suggests that the bond 
lifetime of wt-wt interactions increases then decreases with increasing applied force.  
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Further, these data suggest that the off-rate decreases (enhanced bonding), then increases 
(decreased bonding) as force is increased.  These data show that the catch-slip transition 
seen for rolling velocity describes a more specific property of the bonding mechanism.  
Further, these data show that not only are the overall rolling interactions governed by 
force, but that more specific interactions (the mean stop time in this case) are also 
governed by force. 
 The combination of rolling velocity, mean stop time, off-rate, and viscosity data 
indicates that the bond for wt-wt interactions is regulated by force mechanisms.  To add 
further evidence in support of force dependent platelet interactions with wt vWF 
molecules being regulated by a catch-slip transition, our colleagues conducted single 
molecule studies using AFM to determine bond lifetimes and used MD simulations to 
observe possible structural changes from the binding between GPIbα and vWF-A1 under 
applied force [5].    
To study differences in the tether bond, we first observed rolling velocities for 
three wt vWF molecules:  vWF-A1 (Figure 4.1A), vWF-A1A2A3 (Figure 4.1B), and 
whole vWF (Figure 4.1C).  Following wt vWF molecule studies, we studied changes 
using GOF R687E vWF-A1 (Figure 4.6A) and LOF G561S vWF-A1 (Figure 4.6B).  In 
both cases the rolling velocity of platelets interacting with the vWF molecule first 
decreased and then increased with increasing shear stress, with the exception of 
interactions with GOF R687E vWF-A1, which showed only increasing velocity with 
increasing shear stress.   
For whole vWF the rolling velocity did not increase as dramatically as was seen 
for both wt vWF-A1 and wt vWF-A1A2A3 studies.  This result is possibly due to the 
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presence of the RGD sequence found in the whole vWF molecule, but that is omitted in 
the other molecules studied.  It is likely that the RGD sequence binds integrins that were 
present on the platelet surface.  Because platelets were treated with prostaglandin E-1 and 
citrate buffer, they did not activate significantly.  It is possible, however, that some 
integrins were activated at these higher shear stresses, which would cause the platelets to 
move more slowly due to formation of some longer lasting bonds, but not enough to 
result in complete platelet arrest.   
The minimum rolling velocity for platelets interacting with whole vWF molecules 
occurred at 16 dyn/cm2, which is the same minimum observed for both wt vWF-A1 and 
LOF G561S vWF-A1 surfaces (Figures 4.1A and 4.6B, respectively).  Interestingly, the 
minimum observed for platelet interactions with wt vWF-A1A2A3 occurred at a shear 
stress of 8 dyn/cm2 (Figure 4.1B).  Previously, it has been suggested that a decrease in the 
catch-slip transition force indicates a destabilization of the vWF molecule used [86].  
Therefore, the transition occurring at a lower shear stress for wt-A1A2A3 vWF molecule 
could suggest that this configuration of the vWF molecule may be less stable than its wt 
counterparts.   
We have shown that biphasic catch-slip bonds govern wt-wt interactions (here 
and in [5]), which shows that this bond is force dependent, and, therefore that force plays 
an important role in the bonding behavior between GPIbα and vWF molecules.  
However, the same mechanism was not seen for wt GPIbα-type 2B VWD interactions, in 
which the catch bond behavior was absent [5].  Similar results have been reported for 
interactions for selectins bearing single mutations in either the hinge region between 
lectin and EGF domains in L-selectin [68] or on the ligand binding surface of the L-
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selectin molecule [69].  For these molecule pairs, the mutations in the hinge region 
reduced the bond lifetimes at low forces and reduced the shear threshold [68], while 
mutations in the L-selectin binding site surface eliminated the shear threshold [69].   
Further, we show the novel observation that platelet-LOF interactions under fluid 
forces retain the catch-slip transition when subjected to fluid shear stress (Figures 4.7B 
and 4.7C), but this transition occurs at a different shear stress than seen in wt-wt 
interactions (Figure 4.7).  Our data show that at physiological temperatures, GOF and 
LOF mutations each differ from wt vWF-A1, but in unique ways (Figures 4.1, 4.6, and 
4.7).  These data together suggest that although the clinical observation for VWD 
diseases 2M and 2B are similar, the mechanism for the tether bond dissociation is 
different.     
To further study the changes introduced by mutations in vWF, the mean stop 
times for each vWF-A1 molecule were calculated and compared.  Here we report that as 
shear stress is increased, the mean stop time increases, then decreases, for each type of 
vWF-A1 molecule studied reflecting the catch-slip transition seen in the rolling velocity 
data for wt-wt interactions (Figure 4.1A).  For wt-wt interactions at 37oC both the rolling 
velocity and the mean stop time data catch-slip transitions occur at 16 dyn/cm2 (Figures 
4.1A and 4.3A), which is similar to the rolling velocity transition shear stress we and 
colleagues reported for wt-wt interactions at room temperature [5].  Further, the catch-
slip transition seen in mean stop times is present for all types of vWF-A1 molecules.  
Mean stop time data suggests how the off-rate or bond lifetime for each interaction is 
modulated.   Our data shows that the transition force for LOF G561S vWF-A1 is greater 
than that for wt vWF-A1, which is greater than that for GOF R687E vWF-A1 (Figure 
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4.7).  These data suggest that greater force is required for maximum bond lifetime for 
LOF G561S vWF-A1 compared to wt vWF-A1, while less force is required for GOF 
R687E vWF-A1 compared to wt vWF-A1.   
Recently, Auton et al. [86] studied the thermodynamic stability of vWF-A1 wt 
and mutant molecules.  They showed for single molecule AFM data that the catch-slip 
transition for bond lifetimes also existed for both types of mutants and wt vWF-A1.  
Further, their AFM data and thermodynamic data show that the transition for GOF 
mutations in vWF-A1 occurs at lower forces than seen for wt vWF-A1, which occurs at 
lower forces than for LOF mutations in vWF-A1.  The mean stop time data shown here 
(Figure 4.3) suggest that the thermodynamic data presented by Auton et al. [86] are 
consistent with GPIbα-vWF interactions under physiological flow conditions.  
To gain a better understanding of the bonding behavior of LOF vWF-A1 
mutations compared to wt vWF-A1 molecules, we studied on-rate indicators by 
measuring and quantifying tethering frequency (Figure 4.9).  Here we calculate the 
percentage of cells tethered in one minute (Figure 4.9A) and the number of cells that 
tethered per minute (Figure 4.9B).  The percentage of first time platelet tethers for 
interactions with wt vWF-A1 and LOF G561S vWF-A1 were similar at lower shear 
stresses, but the percent tethered was greater for wt vWF-A1 compared to LOF G561S 
vWF-A1 at higher shear stresses (Figure 4.9A).  The number of cells tethering was 
similar for both wt and LOF G561S vWF-A1 molecules (Figure 4.9B).  Because the 
number of tethers per minute was similar, but the percent tethered was greater for wt 
vWF-A1 compared to LOF G561S vWF-A1 at higher shear stresses, this data suggests 
that the wt vWF-A1 molecule has more successful interactions with platelets.  Because 
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the percent of platelets tethered and the number of tethers per minute are determine by 
observing first time tethers, these data suggest information about the on-rate.  At the 
lower shear stresses both the percent tethered and the number tethering per minute are 
similar, suggesting that the on-rate for these two vWF-A1 molecules is similar at these 
shear stresses.   Together with the changes seen in mean stop time (Figure 4.7) and force 
dependency (Figures 4.2 and 4.3) data shown earlier, this data provides further evidence 
that changes in the GPIbα-vWF tether bond are force and not transport dependent.   
Further, in Figures 4.7 A and B, we saw that the mean stop time maximum for 
LOF G561S vWF-A1 (Figure 4.7B) was shifted to a higher shear stress when compared 
to wt vWF-A1 (Figure 4.7A).  Together, these data indicate that at the shear stress where 
the LOF mutant becomes conformationally active, there are few successful tethers, which 
would result in fewer opportunities for GPIbα-vWF interactions.  The decreased number 
of interactions could explain why patients with type 2M VWD bleed.   
The rolling velocity of platelets interacting with different vWF surfaces was 
measured at 37oC and 250 frames per second.  We show that all wt-wt interactions and 
wt-LOF interactions contain a catch-slip transition, while wt-GOF interactions have only 
slip bond behavior.  Further the effects of a change in force, by changing the viscosity, 
were observed for rolling velocities and mean stop times. Mean stop and go time data 
showed differences between the different vWF-A1 molecules and that for wt-wt 
interactions the mean stop time dominated the rolling interactions when comparing mean 
stop and go times.   Transient tethering lifetime and first time tethering measurements 
give insight into the kinetics of the GPIbα-vWF tether bond.  
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These observations, over a range of shear stresses, reveal the presence of catch-
slip transitions at shear stresses that may reflect changes in vWF structure not only for 
wt-wt interactions, but also for wt-LOF vWF-A1 (rolling and mean stop time data) and 
wt-GOF vWF-A1 (mean stop time data) interactions.  Additional studies will lead to a 
greater understanding of how naturally occurring mutations in vWF result in each type of 
VWD studied.  The data shown here provides details of the GPIbα -vWF tether bond and 
show differences that exist between different types of mutations in the vWF molecule, 
and hence between type 2M and type 2B VWDs.  Here the data provide insight into a 
possible reason bleeding is seen for both GOF and LOF mutations in vWF.  For GOF 
type 2B VWD, there are likely prolonged lifetimes for platelet interactions with GOF 
R687E vWF-A1 at the lowest shear stresses studies, which result in platelet binding to 
soluble vWF, effectively clearing platelets from the bulk fluid, so there are not enough to 
interact at sites of vascular injury.  For LOF type 2M VWD mutations, there is decreased 
adhesion between platelets and LOF vWF mutants.  Because the catch-slip transition, 
where bonds last for the longest time, is at higher shear stress, and the likelihood of a 
successful tethering event is decreased at these shear stresses, it is likely that fewer 
successful GPIbα-vWF interactions occur when the LOF mutations in vWF are present.  
Together these observations suggest that bleeding may occur for type 2M mutants 
because the shear stress where these mutants are most likely to successfully bind platelets 
are too high to allow for enough cells to be available at the sites of injury.  Determination 
of the biomechanical and kinetic functions of wt and mutant molecules has helped us 
elucidate the possible physiological mechanisms inherent in interactions between GPIbα 
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and vWF leading to a better understanding of both type 2B and type 2M VWD bleeding 
disorders.   
 Finally, we conducted preliminary studies to characterize the effect of the 
presence of the protease ADAMTS-13.  Defects in ADAMTS-13 result in thrombus 
formation and are a cause of TTP, which also results in patient bleeding [65].  Here we 
study the bond lifetime of GPIbα-vWF interactions in the presence and absence of 
ADAMTS-13 (Figure 4.10).  At shear stresses lower than 32 dyn/cm2, the bond lifetimes 
for interaction in the absence of ADAMTS-13 (Figure 4.10, open squares) are greater 
than the bond lifetimes for interaction in the presence of ADAMTS-13 (Figure 4.10, open 
triangles).  Above, and including 32 dyn/cm2, the bond lifetimes either follow the same 
trend or are similar (32 dyn/cm2 and 64 dyn/cm2).  These data indicate that at most shear 
stresses and at all lower shear stresses the presence of ADAMTS-13 decreases the bond 
lifetime, which increases the off-rate.  Therefore, the presence of the enzyme enhances 
bond dissociation.  These data agree with the observation that when ADAMTS-13 is 
present thrombus formation is prevented at sites of vascular injury.  When the enzyme is 
absent the bond lifetime is increased, which is in agreement with aggregate formation 
seen when ADAMTS-13 is defective or missing [65].  These data begin to offer an 
explanation for thrombus formation seen in TTP patients.   
 Overall, the data presented in this chapter provides evidence to explain the 
bonding mechanism underlying three vWF bleeding disorders: type 2B VWD, type 2M 
VWD, and TTP.  Further, this bonding data offer possible explanations of why patients 




CHAPTER 5:  OBSERVATIONS UNDER SHEAR STRESS REVEAL 
DIFFERENCES FOR INTERACTIONS BETWEEN WT AND GOF 




In Chapter 4, we saw that mutations in vWF molecules resulting in type 2B or type 
2M VWD change the bonding behavior between GPIbα and vWF.  Now in Chapter 5, we 
study mutations found in the GPIbα molecule rather than the vWF molecule.  As with 
VWD mutations, pt-VWD mutations may lead to abnormal interactions between GPIbα 
and vWF resulting in mild to moderate bleeding.   These GOF mutations in the GPIbα 
molecule have enhanced adhesion of the GPIbα receptor resulting in clearance of 
hemostatically active large vWF multimers from the blood plasma [88].  Two naturally 
occurring mutations are G233V [89] and M239V [90], both of which are valine 
substitutions.  Additional valine substitutions have previously been screened and studied 
[91]. Our lab has previously shown that the GOF mutation K237V mutation showed the 
most dramatic decrease in rolling velocity compared to wt GPIbα [91].  For this reason, 
the K237V mutation was selected to represent GOF GPIbα mutations in these studies.  
GOF mutations in GPIbα have kinetics similar to those seen for the GOF mutations in the 
vWF molecule [8].  Further, it has been suggested that changes in rolling velocities at 
shear stresses higher than those studied here indicate that kinetics play an important role 
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in modulating the binding between GPIbα and vWF [16].   The kinetics of GPIbα-vWF 
interactions have previously been studied by several groups and it has been seen that 
there are rapid interactions between GPIbα and vWF [21-23, 27].  Based on these 
observations there is no consensus on whether on-rate or off-rate regulates rolling for wt 
and GOF GPIbα interactions, though our lab previously observed that both on-rate and 
off-rate may regulate rolling interactions [16].     
To further investigate the mechanics of the tether bond, interactions were captured at 
250 frames per second and a frame-by-frame analysis of these interactions was 
conducted.  The stages in bonding of a single tether were analyzed [17] and characterized 
in stages as either a stop or a go as described in Methods section 3.13.  Here we analyze 
binding behavior to better understand how the changes seen in mutants associated with 
pt-VWD occur at the tether bond level.  We show that the rolling velocity and bonding 
behavior provide additional insight into how GPIbα and vWF regulate rolling, and show 
for the first time that CHO cells expressing GOF K237V GPIbα rolling on wt vWF-A1 
molecules may be regulated by transport rather than force mechanisms.  Taken together, 
these data provide details of the GPIbα-vWF tether bond and the differences that exist 
between wt and GOF mutations in GPIbα.   
 
5.2 Results 
5.2.1 Rolling Velocities for CHO Cells Expressing wt GPIbα Interacting with wt vWF-
A1 
The rolling velocities of CHO cells expressing wt GPIbα were calculated for interactions 
with wt vWF-A1.  The rolling velocity first decreases and then increases with increasing 
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shear stress (Figure 5.1), with a transition shear stress at 0.08 dynes/cm2.  Because CHO 
cells are much larger than platelets (~14 μm versus ~1.5 μm in diameter, respectively), to 
compare this data to the platelet data from Chapter 4 the force on the bond at the 
transition shear stresses was determined as described in Methods section 3.15, and are 
shown here in Table 5.1.  As seen in Table 5.1, the force on the bond for CHO cells 
expressing wt GPIbα rolling on wt vWF-A1 is similar to that for platelets rolling on wt 
vWF-A1A2A3.   
 























Figure 5.1: Rolling velocities of CHO cells expressing wt GPIbα interacting with wt vWF-A1.  Data 
represent mean ± SEM and n = 3 to 33 cells.  
 
 






































5.2.2 Rolling Velocities for CHO Cells Expressing GOF K237V GPIbα Interacting with 
wt vWF-A1 
The rolling velocities of CHO cells expressing GOF K237V GPIbα were 
calculated for interactions with wt vWF-A1.  The rolling velocity only increases with 
increasing shear stress (Figure 5.2) indicating that the catch bond seen for wt-wt 
interactions is lost for this mutant.   



























Figure 5.2: Rolling velocities of CHO cells expressing GOF K237V GPIbα interacting with wt vWF-
A1. Data represent mean ± SEM and n = 41 to 134 cells.  
  
 
5.2.3 Mean Stop Time for CHO Cells Expressing wt GPIbα Versus GOF K237V GPIbα 
Interacting with wt vWF-A1 
Mean stop time for CHO cells expressing wt GPIbα rolling on wt vWF-A1 

























Figure 5.3: Mean stop times of CHO cells expressing wt or GOF K237V GPIbα interacting with wt 
vWF-A1. Data represent mean ± SEM and n = 3 to 22 cells.  
 
Mean stop time for CHO cells expressing GOF K237V GPIbα rolling on wt vWF-A1 
(Figure 5.3, open triangles) only decreases with increasing shear stress.  Further, at 
lowest shear stresses the mean stop time for GPIbα carrying the GOF mutation is greater 
than those for wt GPIbα, suggesting that the bonds for GPIbα which carry the GOF 
mutation last longer than those for wt GPIbα.  Because the mean stop time is larger for 
the GOF mutant at lowest shear stress compared to wt GPIbα, these data suggest an 
explanation of why aggregates form when GOF mutations are present.  When the 
molecule pair comes together the bonds last longer for GPIbα molecules carrying a GOF 
mutation.   
 
5.2.4 Effects of Viscosity on Rolling Velocity for CHO Cells Expressing wt GPIbα 
Interacting with wt vWF-A1 
In Figure 5.4 CHO cells expressing wt GPIbα were perfused across wt vWF-A1 
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Figure 5.4: Effect of viscosity on the rolling velocities of CHO cells expressing GOF K237V GPIbα 
interacting with wt vWF-A1. Data represent mean ± SEM and n = 19 to 134 cells.  
 
The addition of 6% Ficoll increases the viscosity at a given shear rate by 1.8 times.  Here, 
the curves for data with and without 6% Ficoll align when plotted versus shear rate 
(Figure 5.4A).  In contrast, when rolling velocities are plotted against shear stress, the 
curves do not align (Figure 5.4B).  Together, these data suggest that the bonding 
mechanism may be transport, rather than force, dependent.    Because they align with 
shear rate, this data suggests that transport governs rolling velocity interactions. 
 
5.3 Discussion 
Analyzing interactions between GPIbα and vWF molecules shows differences 
between wt vWF molecules and vWF molecules with mutations causing pt-VWD.  The 
pt-VWD mutation used in these studies was K237V.  This mutation shows enhanced 
binding both in rolling studies [16, 91] and kinetic studies [16] similar to other GOF 
GPIbα mutations [16, 23, 91-93].   
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Here we show that CHO cells expressing wt GPIbα interacting with wt vWF-A1 
display a biphasic rolling velocity profile.  In Figure 5.1, the rolling velocity first 
decreases, then increases with increasing shear stress.  This trend suggests that the CHO 
cells expressing wt GPIbα are rolling more slowly, and therefore, the bond is lasting for a 
longer time, a trend indicative of a catch bond.  Then, as shear stress is further increased, 
the rolling velocity increases with increasing shear stress, suggesting that the bond is 
lasting for increasingly shorter times, a trend indicative of a slip bond.  This trend 
parallels the trend we saw for platelets rolling on wt vWF-A1 (Figure 4.1A).  As 
described in Chapter 4, such catch-slip transitions have been previously shown for both 
selectin interactions [17, 18, 78] and interactions between bacterial FimH and mannose 
residues on glycoproteins [72, 87].  Although these trends are the same, the transition 
force is lower for CHO cell interactions compared to platelet interactions on wt vWF-A1 
(Figure 5.1 and 4.1 and Table 5.1).  A possible reason for this result may be that by 
isolating the GPIbα receptor and expressing it on CHO cells, the mechanics of binding 
could be slightly altered resulting in a decreased catch-slip transition shear stress.  
Alternatively, these data could mean that although wt GPIbα and vWF have similar 
binding characteristics in clinical tests [8], there may be some differences in the 
mechanisms at the bond level when comparing isolated wt GPIbα and GPIbα bearing 
platelets.     
To further study the role of GPIbα in GPIbα-vWF interactions, we studied the 
interactions between CHO cells expressing GOF K237V GPIbα rolling on wt vWF-A1.   
Here we show in Figure 5.2 that the catch bond at the lowest shear stresses seen for wt-wt 
interactions (Figure 5.1) is lost resulting in a pure slip bond for these rolling interactions.   
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These results also parallel the results seen for wt GPIbα (platelets) rolling on GOF vWF-
A1 (Figure 4.1A).  Although the two diseases associated with either a mutation in GPIbα 
or a mutation in vWF are distinct, they result in a similar clinical diagnosis [8].  It is 
therefore reasonable to expect the bonding mechanisms underlying each distinct mutation 
to be similar as is seen in our data.  Therefore, these data using CHO cells expressing wt 
or GOF GPIbα suggest a mechanism for pt-VWD aggregate formation.  Loss of the catch 
bond could result in longer bond lifetimes for GOF mutants at shear stresses where wt 
molecules would be in the catch bond region.  Because lifetimes are increased, bonds last 
longer allowing aggregates to form.   
To further investigate these interactions, and in particular bond lifetimes, the rolling 
interactions data was extended to determine the mean stop time for wt-wt and GOF-wt 
interactions.  Our results show distinct mean stop time patterns for each wt and GOF 
mutant GPIbα (Figure 5.3).  Here we show that the mean stop time for CHO cells 
expressing wt GPIbα interacting with wt vWF-A1 first increases, then decreases with 
increasing shear stress (Figure 5.3, open squares).  This data mirrors the rolling velocity 
data for wt-wt interactions seen in Figure 5.1.   While rolling velocity is decreasing 
(Figure 5.1), the mean stop time is increasing (Figure 5.3).  After the catch-slip transition 
the opposite is observed, where rolling velocity increases (Figure 5.1), while mean stop 
time decreases (Figure 5.3).  Further, we observe that the mean stop time for CHO cells 
expressing GOF K237V GPIbα interacting with wt vWF-A1 decreases with increasing 
shear stress (Figure 5.3, open triangles).  Again, the mean stop time data is consistent 
with the rolling velocity data in that as the rolling velocity is increasing (Figure 5.2), the 
mean stop time is decreasing (Figure 5.3) indicating that as the shear stress is increased 
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the bond lifetime is decreasing.  The results seen here in Figure 5.3 add evidence that the 
wt-wt bond is regulated by bond lifetime and hence a force mechanism.   
To further investigate the role of force on the bonding mechanism, CHO cells 
expressing GOF K237V GPIbα interactions with wt vWF-A1 were studied with or 
without the presence of 6% Ficoll, which increases the shear stress at a given shear rate 
by 1.8 times.  In Figure 5.4, we show that the rolling velocity curves for CHO cells 
expressing GOF K237V GPIbα interacting with wt vWF-A1 align when plotted against 
shear rate (Figure 5.4A), while the curves do not align when plotted against shear stress 
(Figure 5.4B).  The data here for CHO cells expressing GOF K237V GPIbα suggest that 
there is transport dependence in the bond for these GPIbα mutations.  The data in Figures 
5.3 and 5.4 suggest that the balance between force and transport are likely important for 
GOF mutations in GPIbα. 
Rolling velocity of CHO cells expressing wt or GOF GPIbα interacting with wt vWF-
A1 surfaces was measured at 37oC and 250 frames per second.  Differences in the shape 
of rolling velocity curves were observed.  Further the effects of a change in force, by 
changing the viscosity, were observed for rolling velocities. Mean stop time data showed 
differences between the different GPIbα molecules and that for wt-wt interactions the 
mean stop time was biphasic as were rolling velocities.    
These observations, over a range of shear stresses, reveal the presence of catch-slip 
transitions at shear stresses that may reflect changes in GPIbα structure.  Further studies 
reveal the loss of this biphasic bonding behavior for CHO cells expressing GOF K237V 
GPIbα interacting with wt vWF-A1.  Additional studies will lead to a greater 
understanding of how naturally occurring mutations in GPIbα result in pt-VWD.  The 
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data shown here provides details of the GPIbα-vWF tether bond and show differences 
that exist between different wt and GOF GPIbα molecules.  Determination of the 
biomechanical and kinetic functions of wt and mutant molecules will help elucidate the 
physiological mechanisms inherent in interactions between GPIbα and vWF.  This 
analysis may lead to a better understanding of pt-VWD bleeding disorders and how they 




CHAPTER 6: CONCLUSIONS 
 
 
6.1  Summary 
In this thesis project the bonding interactions under fluid shear stress between GPIbα 
and vWF molecules in their wt and disease causing mutant forms were studied.  We 
examined the rolling and tethering interactions between GPIbα and vWF molecules to 
determine the mechanisms underlying interactions at the bond level between these two 
molecules.  In Chapter 4 platelet interactions with wt and mutant vWF were studied.   
In Chapter 4, we studied the bond mechanics when VWD mutations were present.  
For these studies, one type 2B mutation (GOF R687E) and one type 2M (LOF G561S) 
vWF mutation were selected.  First, we studied the interactions for platelets and various 
wt vWF molecules and show that all wt-wt interactions have biphasic rolling velocity 
curves indicating catch-slip transitions are present for each wt molecule, which is similar 
to data we and our colleagues presented previously [5].  Further, wt molecules were 
compared with vWF molecules bearing type 2B VWD and type 2M VWD mutations.  
Rolling velocities for platelets on LOF G561S vWF-A1 retained the catch-slip transition, 
while rolling velocities for platelets on GOF R687E vWF-A1 displayed only slip bonding 
behavior.   
To further study the mechanism underlying these interactions, the rolling 
interactions were analyzed to obtain mean stop time.  In comparing mean stop time data 
for wt vWF-A1, LOF G561S vWF-A1, and GOF R687E vWF-A1 we saw that all three 
vWF molecules had a biphasic relationship with increasing shear stress.   Further, the 
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maximum stop time was shifted to a lower shear stress for the GOF vWF-A1 mutant and 
to a higher shear stress for the LOF vWF-A1 mutant when compared to wt vWF-A1.  
When compared with data presented by Auton et al. [86], this data indicates that the 
mutations in the vWF-A1 domain likely affect the stability of the vWF-A1 domain and 
subsequently its ability to bind to platelet GPIbα.  By being less stable at a lower shear 
stress compared to wt vWF-A1 molecules (more susceptible to force compared to wt 
vWF-A1 at its normal transition shear stress), it is likely that GOF vWF-A1 molecules 
become conformationally active at these low shear stresses and are able to participate in 
the enhanced binding that is characteristic of type 2B VWD.   By becoming more 
stabilized at higher shear stresses compared to wt vWF-A1 molecules, LOF vWF-A1 
molecules likely become conformationally active at shear stresses where they are not able 
to bind platelets effectively because there are a decreased number of successful 
interactions at these higher shear stresses.  Together these bonding observations combine 
to provide a possible explanation of the decreased binding that is characteristic of type 
2M VWD.   
To further study the bonding behavior of the GPIbα-vWF tether bond we show 
that the mean stop and go times for platelet interactions with wt vWF-A1 molecules 
differ greatly.  Together mean stop and go time data for platelets interacting with wt 
vWF-A1 suggest that the bond lifetime regulates wt-wt interactions subjected to fluid 
shear stress, which is consistent both with data presented here as well as data previously 
presented [5].  Further, the mean go time is constant compared to the mean stop time, 
suggesting the time spent by the cell moving forward would be unaffected by changes in 
fluid shear stress when compared to changes in the time the cell spends stopped.  Because 
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the mean go time does not directly measure on rate and instead is an indicator of the total 
time moving forward, which includes on-rate as well as other forward motions, mean go 
time data suggests that transport mechanisms may not be as important as force dependent 
mechanisms.   However, mean stop time data suggests platelet interactions with wt vWF-
A1 are force dependent.   
To gain a better understanding of the role of force for the GPIbα-vWF tether 
bond, the effect of increasing medium viscosity was studied for rolling velocity and mean 
stop time of platelets interacting with wt vWF-A1.  The resulting data shows that when 
the viscosity of the platelet suspension buffer is increased 1.8 times, the data aligns when 
plotted with respect to shear stress, but not when plotted with respect to shear rate.   
These results indicate that both rolling interactions (both here and in [5]) and mean stop 
times for platelets and wt vWF-A1 interactions are force, rather than transport dependent.   
In addition, the bond life times were measured as kinetic dissociation or off-rates 
for GPIbα-vWF interactions.  Here we show that interactions of platelets with both wt 
vWF-A1 and LOF G561S vWF-A1 have a biphasic off-rate profile with the off-rate 
decreasing with increasing shear stress, then transitioning to the off-rate increasing with 
increasing shear stress, which is consistent with previous data from us and our colleagues 
[5, 86].  Because off-rate is a direct measurement of how force affects the bond, these 
data indicate that force plays an important role in the presence of a catch-slip transition 
for both wt vWF-A1 and LOF G561S vWF-A1. 
Preliminary studies looking at the transport mechanism were conducted by 
observing first time tethering events to calculate on-rate indicators.  Here we see that a 
similar number of tethers are formed per minute for both wt vWF-A1 and LOF G561S 
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vWF-A1.  However, at the higher shear stresses studied the percent of cells at the surface 
that are tethering is greater for wt vWF-A1 compared to LOF G561S vWF-A1.  
Combining these results with those seen for changes in mean stop times and force 
dependency data, this data adds to the evidence that GPIbα-vWF interactions are force 
dependent, since the since at lower shear stresses these on-rate related data are similar for 
wt vWF-A1 and LOF G561S vWF-A1.   
Finally, in Chapter 4 we study a third bleeding disorder, TTP, which also results 
in patient bleeding due to an inactive form of or the absence of ADAMTS-13.  Our 
preliminary data shows decreased bond lifetime in the presence of ADAMTS-13 for 
platelet interactions with whole vWF indicating that there is increased dissociation when 
ADAMTS-13 is present.  These data suggest that in the absence of ADAMTS-13 the 
dissociation rate is decreased indicating that the GPIbα-vWF bonds last longer and 
provide evidence for the observation that when the enzyme is absent, platelet aggregates 
form preventing normal hemostasis at sites of vascular injury.  
In Chapter 5 we studied the bond mechanics for mutations in the GPIbα receptor 
causing pt-VWD.  For these studies the GPIbα GOF K237V mutation was selected.  
Rolling velocities for wt-wt interactions were biphasic, while rolling velocities for CHO 
cells expressing GOF K237V GPIbα interacting with wt vWF-A1display monophasic 
behavior only.  Both results are similar to the results seen for platelet interactions with wt 
vWF-A1 and GOF R687E vWF-A1 and indicate there may be catch-slip bond behavior 
for wt-wt interactions, while there is only slip bond behavior for GOF mutations in 
GPIbα.   
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To further study the mechanism underlying these interactions, the rolling interactions 
were analyzed to obtain mean stop time.  Mean stop times for wt-wt interactions are 
biphasic, while they are monophasic for CHO cells expressing GOF K237V GPIbα 
interacting with wt vWF-A1.  These data indicate there is a catch-slip transition for wt-wt 
interactions, while there is only a slip bond for GOF GPIbα-wt interactions.  The mean 
stop time is larger for the GOF mutant at lowest shear stress compared to wt GPIbα, 
these data suggest a possible explanation of why aggregates form when GOF mutations 
are present:  when the molecule pair comes together the bonds last longer for GPIbα 
molecules carrying a GOF mutation.   
To gain a better understanding of the role of force for the GPIbα-vWF tether bond, 
rolling velocity for CHO cells expressing GOF K237V GPIbα interacting with wt vWF-
A1 was measured in the presence or absence of increased viscosity medium.  When the 
data for each condition (with or without an increase in viscosity) are plotted with respect 
to each shear stress and shear rate, the data align with shear rate, but not necessarily with 
shear stress.  Because they align with shear rate, this data suggests that transport may 
govern rolling velocity interactions.   
Overall, these data indicate a mechanism by which wt-wt interaction prevent 
aggregate formation and platelet clearance seen for GOF mutations both on the vWF and 
the GPIbα molecules.  Further, these studies give greater insight into how the bonding 
mechanisms wt-mutant interactions differ from wt-wt interactions and how they may 
explain bleeding observations seen in disease states.  The data presented in this 
dissertation suggest mechanisms that offer possible explanations for the bleeding seen in 
type 2B VWD, type 2M VWD, and pt-VWD, by providing insight into how the binding 
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between GPIbα and vWF can be increased (type 2B VWD and pt-VWD) or decreased 
(type 2M VWD).   
 
6.2 Future Work 
Future studies will seek to further determine the role of both force and transport in the 
binding mechanism between GPIbα and vWF.  These studies will elucidate the degree to 
which each type of mechanism is involved in normal hemostasis as well as in cases 
where VWD mutations and pt-VWD mutations are present.  These studies will round out 
the analysis of disease mutations presented in this dissertation and will include rolling 
velocities and rolling parameters in the presence and absence of increased viscosity for 
mutations not studied here (platelets with LOF G561S vWF-A and GOF R687E vWF-
A1).  Further, mean stop times will be determined for platelet interactions with LOF 
G561S vWF-A1.  Additionally, transient tethering lifetimes for platelet interactions with 
GOF vWF-A1 and for CHO cells expressing GOF K237V with wt vWF-A1 will be 
completed to directly measure the off-rate of the GPIbα-vWF tether bond when these 
GOF mutations are present.  To observe the role of on-rate and transport mechanisms, the 
tethering frequency of all disease mutations will be measured.  There are two sources for 
this type of data.  The first will come from rolling interactions using the stop-go model 
used to determine mean stop times presented in this dissertation. These data will be the 
number of events per second (frequency) for each stop and go events in rolling 
interaction data.  The second type of data will come from tether rate data that describes 
the behavior of first time tethering events and is a more direct measure of on-rate 
behavior.  These types of analyses have previously been used to describe selectin 
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interactions [17, 94]. This set of experiments will provide a more complete the story for 
force and transport dependence of the GPIbα-vWF tether bond for the diseases studied 
for this dissertation.   
Because GOF mutations causing both type 2B VWD and pt-VWD are thought to 
cause a similar physiological response (aggregates in the bulk fluid), it is also likely that 
there are similarities for LOF mutations causing type 2M VWD and Bernard Soulier 
Syndrome.  To study the latter mutations, rolling interactions, transient tethering 
lifetimes, and tethering frequency data for CHO cells expressing LOF Q232V GPIbα 
interacting with wt vWF-A1 will be measured and compared to results for platelets 
interacting with LOF G561S vWF-A1.  Combining these studies will provide a fuller 
picture of the GPIbα-vWF tether bond and the changes that occur when bleeding 
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